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ABSTRACT
The human gut microbiome is believed to play an integral role in host health and
disease. In a microbial community, associations between constituent members play an
important role in determining the overall structure and function of the community. To
understand the nature of bacterial associations at the species level in healthy human
gut microbiomes, we analyzed previously published collections of whole-genome
shotgun sequence data, from fecal samples obtained from four different healthy human
populations. Using a Random Forest Classifier, we identified bacterial species that were
prevalent in these populations and whose relative abundances could be used to
accurately distinguish between the populations. Bacterial association networks were
also constructed using these signature species revealed conserved bacterial
associations across populations and a dominance of positive associations over negative
associations, with this dominance being driven by associations between species that
are closely related either taxonomically or functionally. Functional analysis using protein
families suggests that much of the taxonomic variation across human populations does
not foment substantial functional differences. Next, multiple external healthy controls
from the same geographical regions (American population) were compared to
Inflammatory Bowel Disease (IBD) samples from the American population using
shotgun sequencing data. We identified 34 bacterial species that were significantly
elevated in IBD samples, relative to all control groups. These species elevated in IBD
appear to play important roles in the healthy control groups, but it is possible that their
over-abundance has deleterious effects on the host, possibly due to many of these
ii

bacteria being involved in mucin degradation, immune modulation, antibiotic resistance,
and inflammation. We also identified differences in functional capacities between IBD
and healthy controls, and linked the changes in the functional capacity to previously
published clinical research and to symptoms that commonly occur in IBD, such as rectal
bleeding, diarrhea, vitamin K deficiency, and inflammation.
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CHAPTER 1: INTRODUCTION
The microbiome is defined as the community of microbes that exists throughout a
host, both and internally and on external surfaces, and is believed to play an important
role in maintaining host health.(Methé et al. 2012) This community of microbes exists as
a complex consortium whose ecological and metabolic interactions are believed to
heavily influence host health, especially in host metabolism, immunological modulation
and development, mucosal regeneration and homeostasis, cell signaling, and pathogen
resistance (Rahaman, n.d.; Thaiss et al. 2016; Das and Nair 2019; Shreiner, Kao, and
Young 2015; Kostic, Xavier, and Gevers 2014; Kho and Lal 2018; Petersen and Round
2014). The disruption of this community, commonly termed ‘dysbiosis’, has been
associated with a multitude of varying diseases such as obesity, diabetes,
cardiovascular disease, inflammatory bowel disease (IBD), and various cancers (Koren
et al. 2011; Karlsson et al. 2012; 2013; Franzosa et al. 2019; Becker, Neurath, and
Wirtz 2015; Kostic et al. 2013). However, it is difficult to discern if the disruption of the
gut microbiome is a cause or an effect of the associated diseases. Furthermore,
defining what a healthy, or ‘eubotic’, gut microbiome is difficult due to the large number
of bacterial species found in the gut and the large intra-personal variation of the gut
microbiome across human populations (Huttenhower et al. 2012; Johnson et al. 2019).
Identifying what microbiota constitute a healthy microbiome is integral, as one of the
primary translational goals of microbiome research is to identify what a dysbiotic
microbiome is and return it to its healthy state.
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The bacterial compositions of the microbiome are most commonly examined by
DNA sequencing, either by targeted sequencing of a marker gene or by shotgun
sequencing of whole genomes. Targeted sequencing utilizes marker genes, such as the
16S ribosomal RNA gene for bacteria, as a phylogenetic marker (George E Fox et al.
1977). While the gut microbiome is comprised of bacteria, archaea, viruses, and fungi,
most studies focus on the bacterial constituents of the gut microbiome, mainly due to
bacteria being the largest constituents of the microbiome (Kho and Lal 2018).
While targeted sequencing approaches are cheaper and allow for higherthroughput, the highly conserved nature of the 16S rRNA gene and the short lengths of
the sequenced regions makes it difficult to distinguish bacterial species (G. E. Fox,
Wisotzkey, and Jurtshuk 1992; Ranjan et al. 2016). Furthermore, bacterial relative
abundance estimation is obfuscated by the presence of multiple copies of the 16S gene
within many bacterial species and the intragenic variation these copies exhibit (Rastogi
et al. 2009; Ibal et al. 2019). Finally, due to the targeted sequencing only focusing on
one gene, it is difficult to accurately identify the functional capacity of a bacterial
species. In contrast to targeted sequencing, whole genome shotgun (WGS) sequencing
yields more accurate estimates of relative abundances, better taxonomic resolution, and
greater ability to estimate genomic functional capacity (Laudadio et al. 2018; Ranjan et
al. 2016).
Regardless of sequencing methodology, the resulting sequencing data are
compositional in nature due to the fixed number of reads generated by a sequencing
instrument (Gloor et al. 2017). Compositional data are parts of a whole and thus only
2

contain relative information (Pawlowsky-Glahn and Egozcue 2006). Due to the
compositional nature of sequencing data, it can be difficult to analyze differential
abundance, infer associations, or estimate correlations (Aitchison 1982; Jonathan
Friedman and Alm 2012; Tsilimigras and Fodor 2016; Pearson 1896). To mitigate the
issues caused by the compositional nature of the sequencing data, we utilized a
centered log-ratio (CLR) transformation (Aitchison 1982). The CLR transformation
allows to examine the differential abundance data and infer associations without
inducing spurious correlations (Gloor et al. 2017; Tsilimigras and Fodor 2016).
Furthermore, the covariance matrix of log-transformed relative abundance data provides
a good approximation of the covariance matrix of the log-transformed absolute
abundance data enabling us to better model the associations between bacteria (Kurtz et
al. 2015).
Associations within bacterial communities are composed of the direct and indirect
interactions between the constituent bacteria, and are important for understanding the
dynamics underlying the community assembly. Bacterial association networks are
commonly inferred using pair-wise estimation correlation such as the Pearson or
Spearman correlations. However, due to the compositional nature of the sequencing
data used, it is difficult to accurately infer associations, especially due to the possibility
of spurious correlations arising (Pearson 1896; Jonathan Friedman and Alm 2012).
Even if the sequencing is CLR transformed, pair-wise correlation methods are unable to
accurately infer bacterial association networks due to their inability to identify conditional
independence (Kurtz et al. 2015). One way to identify the conditional independences
within the bacterial association networks is to utilize a Gaussian graphical model (GGM)
3

to estimate the underlying covariance structure (Wermuth and Lauritzen 1990).
Furthermore, due to the sparse nature of biological networks, in which most constituents
are not strongly associated, it is important to conduct a sparse estimation of the
bacterial association networks (Jerome Friedman, Hastie, and Tibshirani 2008;
Jonathan Friedman and Alm 2012). Here, we utilize a Gaussian Graphical Model
(GGM) framework in conjunction with a graphical lasso (glasso) to construct bacterial
association networks from the CLR-transformed relative abundance data (Jerome
Friedman, Hastie, and Tibshirani 2008; Loftus, Hassouneh, and Yooseph 2021). These
bacterial association networks are represented as an unweighted graph in which nodes
denote bacterial species and an edge between two nodes denotes an association
between the corresponding bacterial species.
The random forest classifier (RFC) has become an important tool for
classification and feature identification in microbiome research due to its ability to utilize
with non-parametric, ‘noisy’, and multi-dimensional data (Breiman 2001; Díaz-Uriarte
and Alvarez de Andrés 2006; Loomba et al. 2017; Saulnier et al. 2011; Roguet et al.
2018; Shi et al. 2005). The RFC can incorporate bacterial relative abundance data and
metadata to generate a model that account for microbiome taxonomic profiles as well as
subject characteristics, such clinical and demographic characteristics, when classifying
samples. Furthermore, the RFC is able to assign feature importances, numeric values
indicating the relative importance of a feature for achieving a correct classification, to
the input features. These feature importances are helpful for identifying features that
may be informative in relation to the specified sample labels. . One shortcoming of
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these feature importances, however, is their lack of statistical significance. Due to the
stochastic nature of model construction using an RFC, some features may be relatively
important in one instance of an RFC model, but relatively unimportant in another
instance of the RFC model. To enable us to utilize RFC feature importance to
distinguish potentially important features and reduce the dimensionality of our data, we
formulated a framework that allowed us to add statistical significance to the feature
importances.
Importantly, many studies examining the microbiome suffer from a lack of crosscohort consistency making it difficult to generalize findings to populations rather than
just the utilized study groups (Pasolli et al. 2016). One proposed remedy for this lack of
cross-cohort consistency is to utilize external samples from independent cohorts,
especially when comparing diseased and healthy microbiomes, and applying the same
methods and techniques across all samples (Pasolli et al. 2016; Thomas et al. 2019).
To this end, we include two external healthy controls when analyzing IBD samples to
enable us to generalize our findings to a population group, rather than just the study
participants.

By utilizing shotgun sequencing data, we are able to more accurately determine
relative abundances, bacterial taxonomies, and genomic functional capacities.
Furthermore, employing the GGM framework on CLR-transformed data enables to
approximate the covariance structure of the absolute abundances as well as account for
conditional independence between the constituent species (Wermuth and Lauritzen
5

1990; Aitchison 1982). Finally, due to our use of external cohorts, we can corroborate
our findings and arrive at generalizable conclusions that represent the population and
not only the study participants.
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CHAPTER 2: BACTERIAL ASSOCIATIONS IN THE HEALTHY HUMAN
GUT MIROBIOME ACROSS POPULATIONS
Note: This section has been published in part and the citation link is: Loftus, M.,
Hassouneh, S. A.-D., & Yooseph, S. (2021). Bacterial associations in the healthy
human gut microbiome across populations. Scientific Reports, 11(1), 1–14.
https://doi.org/10.1038/s41598-021-82449-0.

Introduction
The community of microbial cells in the human gut is estimated to be comparable
in magnitude to the number of human cells(Sender, Fuchs, and Milo 2016). This
community, deemed the human gut microbiome, is mainly composed of bacteria,
archaea, fungi, and viruses, with bacteria being the largest constituent. These bacterial
cells exist in a complex consortium of ecological and metabolic interactions that
ultimately influence the taxonomic and functional profile of the microbial community, as
well host health. The gut microbiome of healthy individuals is believed to be mainly
symbiotic and is known to play important roles in host metabolism, immunological
modulation and development, cell signaling, pathogen colonization resistance, and
mucosal homeostasis (Kho and Lal 2018; Kostic, Xavier, and Gevers 2014; Thaiss et al.
2016).
The continued stability of this community and its functions, i.e. homeostasis (Das
and Nair 2019; Shreiner, Kao, and Young 2015), is important and its disruption, broadly
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described as ‘dysbiosis’ (Petersen and Round 2014), has been associated with
numerous diseases including, but not limited to: diabetes(Karlsson et al. 2013),
cardiovascular disease(Koren et al. 2011; Karlsson et al. 2012), obesity(consortium et
al. 2013), inflammatory bowel disease(Franzosa et al. 2019),(Becker, Neurath, and
Wirtz 2015), and various cancers(Kostic et al. 2013). However, it remains unclear
whether disease onset is the consequence or cause of the microbiome community
disruption. Furthermore, what constitutes a healthy gut microbiome is still under
investigation due to the overwhelming amount of bacterial species found in the gut, and
the large variation in their carriage rates across human populations and
individuals(Consortium 2012; Johnson et al. 2019). These issues are of great
importance as one of the ultimate goals of microbiome research is to modulate the
community from a ‘dysbiotic’ state into a healthy ‘homeostatic’ one.
Early research towards this goal chose to limit their focus to taxonomic
differences between healthy and disease microbiomes(Villmones et al. 2018; Gevers et
al. 2014; David et al. 2014). While these comparisons are valuable, since the bacterial
community taxonomic profile generally represents the potential metabolic and
transcriptional profiles that are present within the ecosystem; simply profiling the
community fails to acknowledge the underlying bacterial associations and the impact
they exert on both the microbial ecosystem and host health. In fact, many studies within
natural systems and animal hosts have shown that the associations (positive and
negative) between bacteria are an important foundation for the continued stability and
proper functioning of these ecosystems(Zhou et al. 2011; Lupatini et al. 2014; Eiler,
Heinrich, and Bertilsson 2012; Kara et al. 2013; Shetty et al. 2017; Gould et al. 2018).
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As such, it is of great importance to assess the relationships that exist between bacteria
within the healthy human gut microbiome in order to better understand the ecological
associations important for the structure and maintenance of the gut microbiome and its
related processes. Naturally, this raises an important question: are there similarities in
the structural features of bacterial association networks in human gut microbiomes
across healthy populations, and if so, are there conserved associations?

Microbial associations in a community are characterized by both direct and
indirect interactions between the constituents(Hibbing et al. 2010). In this paper, we
depict these associations using a weighted graph (network) in which the nodes
represent bacterial species and an edge between two nodes represents an association
between the corresponding species, with the edge weight capturing the strength of the
association. This framework enables us to model both positive and negative
associations between species, and thus can help to shed light on cooperation and
competition between species in the community. Once a network is constructed, an
analysis of the various topological properties of the network can enable us to decipher
the underlying ecological rules associated with the microbial ecosystem. These
networks also provide the ability to determine the relative importance of species for
ecosystem structure and function.
Microbial association networks are typically constructed from a sample-taxa
count matrix generated by collecting multiple samples from the community and
determining the taxa counts in each sample. With the availability of high-throughput and
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low-cost DNA sequencing technologies, these counts are generated by sequencing the
collected biological samples. Microbiome sequence data are generated either using a
targeted approach, involving the sequencing of a taxonomic marker gene (e.g., the 16S
ribosomal RNA gene)(George E Fox et al. 1977) or using a whole-genome shotgun
(WGS) sequencing approach(Venter et al. 2004). However, estimates of taxa
abundances using 16S rRNA sequences can be confounded by several factors
including the presence of multiple copies and variants of the 16S rRNA gene in
genomes, and the lack of taxonomic resolution in the selected variable region of the
16S gene(Větrovský and Baldrian 2013; Edgar 2018). Conversely, WGS data can be
used to provide more accurate estimates of genome relative abundances as well as
higher resolution taxonomic classification, compared to 16S rRNA data(Ranjan et al.
2016; Laudadio et al. 2018). Regardless of sequencing approach, the taxa count data
generated by DNA sequencing are compositional in nature and provide only relative
abundance information of the constituent taxa(Gloor et al. 2017). This poses challenges
for inferring associations, and the computation of measures like correlation directly from
the observed sequence counts can be misleading(Jonathan Friedman and Alm 2012).
While several methods have been proposed for constructing association networks that
address this challenge(Layeghifard, Hwang, and Guttman 2017), here we use a
Gaussian Graphical Model (GGM) framework on Centered Log-Ratio (CLR)
transformed count data to construct an association network(Aitchison 1982; Kurtz et al.
2015).
We are motivated by the observation that the covariance matrix of a multivariate
Gaussian distribution used to fit log-transformed relative count data provides a good
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approximation to the covariance matrix of the log-transformed absolute count
data(Aitchison 1982). The GGM framework also enables the modeling of conditional
dependencies of the random variables that represent taxa abundances. The adjacency
matrix of the association network that we construct is the inverse covariance matrix (i.e.
the precision matrix) of the underlying multivariate Gaussian distribution used in the
GGM. This graph has the property that an edge exists between two nodes if and only if
the corresponding entry in the precision matrix is non-zero. A zero entry in the precision
matrix indicates conditional independence between the two corresponding random
variables. We also incorporate sparsity in our framework using the l1-penalty norm and
construct sparse association networks using the graphical lasso method
(glasso)(Jerome Friedman, Hastie, and Tibshirani 2008).
In this study we investigate bacterial association networks in gut microbiomes
across four healthy human populations. Previous studies analyzing bacterial association
networks have mainly used 16S rRNA data, and given its lower taxonomic resolution,
these studies have analyzed associations at the genus level(Falony et al. 2016; Jerome
Friedman, Hastie, and Tibshirani 2008)Instead, here we use a large collection of WGS
samples from multiple human populations to investigate bacterial associations at the
species level. We use a machine learning algorithm to identify a set of signature species
that can accurately distinguish between the different healthy populations. Using these
signature species, we construct networks by employing a glasso method that
incorporates a bootstrapping(Efron and Tibshirani 1986) approach to reduce the
number of false positive edges inferred(Su et al. 2017). We analyze these networks to
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assess the theoretical ecology, and potential importance of species within healthy
human gut microbial communities.

Results
Signature Species in the Healthy Human Gut Microbiome
For each cohort, the prevalence of individual species across all samples was
measured and plotted. All cohorts exhibited a skewed bi-modal distribution (Figure 1a).
The first peak in the distribution was centered around a prevalence of 10%, while the
second peak occurred around a prevalence of 90%. This skewed bi-modal distribution
has been previously observed in a microbial community, and organisms that were highly
prevalent were deemed the ‘abundant core’ as they were found to account for the
majority of total sample abundances(Saunders et al. 2016). The 90% prevalent species
set for each cohort consisted of 127 (American), 109 (Indian), 182 (European), and 146
(Japanese) species respectively, and these species were found to account for a large
majority of the total sample proportions, the median values for the cohorts were 0.93
(American), 0.93 (Indian), 0.87 (European), and 0.81 (Japanese) (Figure 1b). Next, we
utilized a Random Forest Classifier (RFC) to determine the effect of prevalence
thresholds on the ability to distinguish between cohorts using the taxonomic profiles of
the constituent samples. The RFC was able to distinguish between cohorts with an F1score >0.85 for all prevalence thresholds (0%, 50%, 90%, 100%), but demonstrated the
highest F1-score at the 90% threshold, even though less than 10% of the original
species remained (Figure 2). Based on this analysis, we define the set of signature
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species to be the union of the prevalent (>90%) species sets from the four cohorts. The
signature species set consisted of 202 species and was used for constructing the
bacterial association network for each cohort. We explored the variability in signature
species relative abundance between samples using principal components analysis
(PCA) applied to the CLR-transformed data (Figure 1c). PCA showed evidence for
separation of samples from the Indian and American cohorts, but ultimately the PCA
only explained a small amount of the total variance (PC1: 11.38%, PC2: 10.91%).

Bacterial Association Networks
Prior to its application on the cohort data, the network inference method with
bootstrapping was tested on synthetic data (see supplemental) notably, most graphtypes were inferred with an F1-score above 0.7 (band: 0.974, hub: 0.885, random: 711,
cluster: 0.692, scale-free: 0.416) (Figure 3a). Furthermore, we demonstrate that as the
sample-to-taxa ratio increases, F1-scores approach 1, and all groups demonstrate
mean F1-scores above 0.9 (Figure 3a). Finally, we observe that our network inference
method tends to underestimate edge weights, and on average the estimated edge
weights are 53.23% of the actual edge weights (Figure 3b). A bacterial association
network was constructed for each cohort using the CLR-transformed relative
abundances of the signature species (see methods). Each network was modeled as an
undirected graph consisting of nodes and edges (Figure 4). At a high-level, differences
in the structure of the four networks were apparent. The European, Japanese, and
Indian networks exhibited a high density of edges occurring between nodes from the
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phylum Firmicutes, whereas the American network had the largest density of edges
existing between nodes from the phylum Bacteroidetes. Positive associations were
dominant in all networks (American: 0.98, Indian: 0.97, European: 0.96, Japanese:
0.96), and negative associations involve nodes from the phylum Firmicutes. Network
topology was studied by calculating the following network properties: average shortest
path length (ASPL), transitivity, modularity, degree assortativity, and genera
assortativity (see methods) (Table 1). These properties were compared to random
networks using Monte Carlo simulations (see supplemental). All cohort networks were
deemed non-random in their topology and exhibited significantly low ASPL (all P-values
< 0.05), significantly high modularity (all P-values < 0.01), significantly high transitivity
(all P-values < .001), significantly high genera assortativity (all P-values < .001) and
significantly high degree assortativity (all P-values < 0.01), relative to the random
networks. The low ASPL within networks suggest that nodes are connected to one
another through short paths within the network. The high transitivity and modularity
indicate that nodes form cliques and networks exhibit compartmentalization (modules),
respectively. Lastly, the high (assortative) degree assortativity and genera assortativity
portrays that nodes tend to form connections to other nodes that have a similar degree
and taxonomy.

Theoretical Ecology based on Bacterial Association Networks
All cohort networks were found to contain highly similar distributions of
association (edge) weights, where positive associations were more frequent and greater
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in magnitude than negative associations (Figure 5a). Furthermore, a large percentage
of associations (American: 40%, Indian: 40%, European: 40%, Japanese: 53%) were
found to be shared with at least one other network and these associations were all
positive (Figure 5b). A conserved structure of 14 associations, composed of 20 species
(Figure 5c), mainly from the genus Bacteroides, was observed to be contained within
all networks (Figure 6). No negative association was retained across networks.
However, viewed at the higher taxonomic rank for those species involved in negative
associations, we observed that across all cohort networks, members from the phylum
Firmicutes were involved in a large percentage of the negative associations (American:
100%, Indian: 100%, European: 62.5% , Japanese: 100%), and specifically these
negative associations were mainly occurring between species from the order
Clostridiales (American: 25%, Indian: 89%, European: 56%, Japanese: 100%) (Figure
7). We next explored the taxonomic relationship between species and their association
type (positive or negative) (Figure 8a), as well as the genome functional profile
dissimilarities, according to Bray-Curtis dissimilarity, between network neighbors against
their association weight (Figure 8b). We found that most positive associations take
place between bacteria that are more taxonomically and functionally similar, while
negative associations were never found between species within the same genus, or
between species with low genome functional profile distance (<0.2).
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Network Cliques and Module Detection
As our networks exhibited both high transitivity and modularity, we sought to
investigate the cliques and modules of species contained within them. We first found all
cliques of three species (1,588 unique cliques) within our networks (see methods). Of
these cliques: 113 were shared in at least 1 other network, 8 were shared across three
networks, and only 1 (Bacteroides caecimuris, Bacteroides fluxus, Bacteroides
thetaiotaomicron) was found in all networks. Species from 66 genera were shown to
participate in clique formation, however, species from the genus Bacteroides were
found to be involved in the largest percentage of cliques (American: 21.0%, Indian:
4.0%, European: 4.9%, Japanese: 5.8%) within most cohort networks (Figure 9).
Interestingly, the cliques that contained species from Bacteroides were also the most
retained (American: 20.9%, Indian: 8.5%, European: 8.5%, Japanese: 10.8%) across all
cohorts (Figure 10).
Following clique analysis, we performed module detection utilizing an
asynchronous Label Propogation Algorithm (aLPA) (see supplemental) which identified
a total of 49 modules (American: 10, European: 11, Indian: 14, Japanese: 14) that
contained 3 or more members (Cordasco and Gargano 2010) (Figure 11). The quality
of network partitioning by the module detection algorithm (performance) was analyzed
(American: 0.96, Indian: 0.98, European: 0.94, Japanese: 0.98) showing that the
majority of edges between nodes were contained within modules (see supplemental).
PCA was utilized to examine the variance between Module Functional Profiles (MFP’s)
of the different cohort (Figure 8c). This analysis revealed MFPs fell within one of four
clusters, and each cohort had representation within each cluster. Taxonomic and
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functional characteristics of the clusters were analyzed. Cluster I contained modules
formed mainly by the genera Streptococcus and Bifidobacterium (Figure 12a). Cluster II
modules were mainly composed of species from the genera Alistipes, Bacteroides, and
Prevotella (Figure 12b). Cluster III modules were dominated by the genera Bacteroides
(Figure 12c). Cluster IV modules were mainly composed of species from the genera
Blautia, Eubacterium, Lachnoclostridium, and Ruminococcus (Figure 12d). Functional
analysis of clusters revealed unique roles in each cluster: Cluster I (increase in toxin
production, protein secretion, anaerobic metabolism, nucleic acid metabolism; decrease
in thiamine biosynthesis), Cluster II (increase in cellular metabolism and protein
degradation; decrease in cell division and signal transduction), Cluster III (increase in
chemoautotrophy, sulfur and phosphorous metabolism, DNA metabolism), and cluster
IV (increase in transcription factors; decrease in roles associated with adaptation to
atypical conditions) (Figure 13).
We next analyzed the sample functional profiles using PCA (Figure 14). PCA
explained a modest amount of variance (PC1: 27.82%; PC2: 5.99%) although samples
between cohorts were found to overlap. When analyzing the Cohort Functional Role
Profiles (CFRP’s), only 11 differences, when comparing the signs (+/-), out of the 113
found roles were found, and only the European cohort exhibited more than two
differences (Figure 15).
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Node centrality analysis
We utilized degree and betweenness centrality measurements to identify “hub”
and “bottleneck” nodes, respectively, within our networks (see supplemental). These
centrality measurements were selected because ‘hubs’ and ‘bottlenecks’ are nodes that
could have strong influence within a network and have been utilized previously to
identify important species within microbial ecosystems(Lupatini et al. 2014; Prettejohn,
Berryman, and McDonnell 2011; Kara et al. 2013). Considering all cohort networks were
deemed assortative in respect to their degree assortativity we did not expect to find
network “hub” nodes. However, we did find that nearly all modules, within each cohort,
were disassortative in their degree assortativity which hinted at “hub” nodes existing
within modules (Figure 16). For these reasons we chose to select the node within each
module that exhibited the highest degree (See Figure 4), and the top 10 nodes within
each network with the highest betweenness. Across all cohorts we found variation in the
species deemed module ‘hubs’ and ‘bottlenecks’ (Figure 17a), although at the genus
level there was a large amount of agreement (Figure 17b). In at least three out of the
four cohorts, species from Bacteroides, Alistipes, Bifidobacterium, Eubacterium, and
Streptococcus were designated as ‘hubs’, whereas species from Bacteroides and
Lachnoclostridium were designated as ‘bottlenecks’.
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Discussion
In this study, we used WGS data in conjunction with a network inference method
that is robust to sequence data compositionality in order to analyze the associations
occurring between species within the healthy human gut microbiome across different
populations. The association networks were constructed utilizing the signature species.
We demonstrated that bacterial association networks, across all cohorts, do not
have the same properties as random networks. However, relative to each other, the
networks of the four cohorts display similar properties. Random networks are known to
contain short average path lengths, low node clustering, and high modularity44,45.
Compared to random networks each cohort network was found to exhibit significantly
shorter average shortest path lengths, significantly higher transitivity (clustering),
significantly higher modularity, significantly higher degree assortativity, and significantly
higher genera assortativity. We posit that the similarities in network properties reflect an
organization of the bacterial community that is important to underlying ecological
processes. For instance, the short average path lengths within our networks could imply
rapid signaling between bacterial species, potentially facilitating swift changes in
community metabolism. This is supported by previous studies demonstrating that the
human gut microbiome exhibits rapid alterations in bacterial metabolism and abundance
in conjunction with change in host diet19.
In addition to exhibiting similar properties, cohort networks also shared a large
percentage of associations (American: 40%, Indian: 40%, European: 40%, Japanese:
53%), including a conserved set of 14 positive associations composed of 20 species.
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These conserved associations may be indicative of strong partner fidelity, important
ecological relationships, or potentially obligate partnerships. Furthermore, we found that
taxonomically and functionally similar species tended to have positive associations. This
finding was unexpected as some previous studies on microbial ecosystems, including
the human gut46–48, have shown negative interactions between bacteria (competition,
predation, etc.) should be the dominant form of interaction49, especially when those
bacteria are taxonomically or functionally alike50. The differences between our results
and the aforementioned research may be due to their use of non-transformed data and
pairwise analysis as well as the use of low-resolution taxonomic sequencing data or invitro analysis33. Our findings would suggest that kin-selection51 (positively associating
with those of similar lineage in order to directly or indirectly pass on ones genes), as
opposed to competitive exclusion52 (bacteria with similar lineage or functionality are
more likely to compete within a habitat), is more prevalent within the healthy gut
microbiome. This observation cannot be excluded as there is precedence within
microbial ecosystems for the co-occurrence of bacteria with similar genetic traits50,53,
and studies on bacterial dynamics in the gut that suggest close relatives to bacteria
currently present in the gut are more likely to be recruited into the community, i.e.
phylogenetic under-dispersion (nepotism) hypothesis54.
Within all cohorts, positive associations were not only the most dominate form of
association, but also the only associations that were shared across networks. This
finding seems logical as within the anoxic environment of the gut, bacterial energy
production is limited which would make positive associations, such as mutual crossfeeding, preferable in order to produce and utilize energy more efficiently55. In addition,
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ecological community theory suggests that partitioning of resources in space and time
drive coexistence56, and bacteria within the human gut microbiota are known to exhibit
diurnal fluctuations57 and exist in distinct spatial organizations58–60. Furthermore,
positive associations between species are also known to alleviate ecosystem stresses
and allow for a greater diversity of organisms to coexist61, and the healthy gut
microbiome has a high level of biodiversity62. However, it is Important to be cognizant
that a positive association between species does not rule out the presence of a negative
interaction completely, as negative interactions between species can still have a net
positive result if an increased survival rate is occurring, as well as to understand that
these positive associations are not always indicative of cooperative activities as they
could simply reflect a common preferred environmental niche61. In contrast to the large
proportion of shared positive associations, negative associations were always unique to
a specific cohort; however, as we viewed the higher-level taxonomic ranking of species
involved in negative associations, we found that across all cohorts most negative
associations were occurring between species from the order Clostridiales. Species from
the order Clostridiales are known to be largely cellulolytic, in that they mainly hydrolyze
the polysaccharide cellulose63. This limited nutritional niche could theoretically create
competition between Clostridiales sp., and in any case, these associations might be
important for community stability as negative associations within microbial communities
are thought to be an important stabilizing force48. While the healthy human gut
microbiome is indeed routinely described as stable62, the low abundance of negative
associations within our networks suggests that the gut microbiome would be more
vulnerable to positive feedback loops between species which could result in instability48.
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We hypothesize that the high modularity found within all cohort networks could mitigate
the vulnerability to positive feedback loops as high network modularity has been shown
to have a stabilizing effect45.
We used a module detection algorithm to identify groups of highly connected
species within our networks. The algorithm identifies modules of species which have
previously been noted to benefit by growing together (e.g. Bifidobacterium sp.)64. As we
analyzed the variance between module functional profiles, using PCA, we found that
modules gravitated towards one of four clusters. Although some cohorts had a greater
proportion of modules within certain clusters, all cohorts had some level of
representation within each cluster. Upon further analysis, we were able to find distinct
functional and taxonomic differences between module clusters, but we were not able to
distinguish overt functional differences between CFRP’s. This implies that a general set
of functions is present in each healthy population regardless of taxonomic differences.
These module clusters may be indicative of niches that are retained in the healthy
human gut microbiome, and the redundancy of multiple modules of a cohort falling
within a cluster is potentially a further stabilizing force for the ecosystem. These findings
agree with previous studies showing comparable communities and high functional
redundancy across gut microbiome data sets53,65.
Lastly, we identified species that acted as “hubs” or “bottlenecks” within the
structure of cohort networks. Notably, we found Bacteroides sp. were designated as
both “hubs” and “bottlenecks” across all networks. Interestingly, Bacteroides sp. were
also found to be the largest constituent of bacterial cliques and these cliques were the
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most retained across all cohorts. Additionally, of the 20 species from the 14 conserved
associations found across networks, most were species belonging to Bacteroides.
These findings suggest that Bacteroides sp. are important drivers of the ecosystem
within the healthy human gut microbiome. Interestingly, previous studies have also
designated Bacteroides sp., such as Bacteroides fragilis and Bacteroides stercosis, as
potentially important (keystone) species within the human gut microbiome66.
It is important to consider the limitations of our study. Our samples originated
from different geographical locations and utilized different preparation procedures both
of which are known to introduce biases24,67,68. Additionally, due to the cross-sectional
nature of our data we are only able to capture snapshots of the gut microbiome and are
unable to examine the dynamics of the ecosystem. Furthermore, we utilized a
reference-based mapping approach for taxonomic classification potentially causing our
classifications to be limited by the genomes available. Finally, the constructed bacterial
networks were undirected, and the study was non-mechanistic which prevents us from
being able to examine the influence individual species have on one another
(unidirectional ecological interactions).
In closing, we have demonstrated that bacterial communities across healthy
human populations are similar in their organization and functional capacities. We have
also revealed that positive associations regularly occur between taxonomically and
functionally related species despite bacterial carriage differences, healthy human gut
microbiomes across populations exhibit less variation (structural and functional) than
previously believed. Our future research will build upon these findings to better
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understand how bacterial associations change within the disease microbiome. Also, by
using the prevalent species, we can minimize the ‘noise’ of bacterial variation across
hosts, especially since low prevalence species may ultimately be transient in nature41.
This could be advantageous as it has been suggested that the most abundant
organisms are the ones that act as “ecosystem engineers”50, and the study of these
organisms would be important to understand how the microbiome responds to
disturbances.
Materials and Methods

Data Acquisition
We utilized 606 WGS fecal samples (1.7 Tbp), which were obtained from four
previously published human gut microbiome studies from four different healthy human
populations (cohorts). Three cohort datasets were downloaded from the NCBI
Sequence Read Archive (SRA): American15 (PRJNA48479; 202 samples), Indian69
(PRJNA397112; 106 samples), and European70 (PRJEB2054; 120 samples). The
Japanese cohort dataset was downloaded from the DDBJ Sequence Read Archive
(DRA): Japanese71 (PRJDB4176; 178 samples) (Figure 18).

Data Pre-Processing
Reads from all samples were first trimmed using Trimmomatic72 (version 0.36)
and then human reads were filtered using BowTie273 (version 5.4.0) and the
GRCh38.p12 (https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.38/) human
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reference genome. After removal of human reads, 15.9 billion high-quality reads
remained. (Figure 19).

Read Mapping and Species-Level Taxonomic Profiling
Reads were mapped to a collection of 10,839 bacterial reference strain genomes
downloaded from RefSeq74, using Bowtie2. The read mapping information was
analyzed using a probabilistic framework based on a mixture model to estimate the
relative copy number of each reference genome in a sample. This framework used an
Expectation-Maximization (EM) algorithm to optimize the log-likelihood function
associated with the model75. The EM algorithm was found to be highly accurate when
benchmarked using simulated WGS reads produced by WGSim
(https://github.com/lh3/wgsim) (Figure 20). Sub-sampling and benchmark testing of
sample read mapping counts showed that a read depth of 250,000 mapped reads at a
noise threshold of 1e-5 correlated well with samples mapping over 5 million mapped
reads (R2 > 0.85, Figure 21). Any bacterial strain found in a sample below 1e-5 relative
abundance was considered statistical noise and was dropped to an abundance of 0.
Strains were then grouped by their species classification and their relative abundances
were summed to produce species abundances.

Bacterial Genome Annotation and Functional Profiles
All bacterial reference genomes were functionally annotated in-house to create
reference strain functional profiles. Before genome annotation, we utilized CheckM76
30

(v1.0.13) to ensure that these reference genomes were mostly complete (Figure 22).
Prodigal77 (version 2.6.3) was used to identify genes, and generate protein sequence
translations, which were then provided to InterProScan78 (version 5.39-77.0) to find
matches to protein families using the TIGRFAM79 (version 15.0) database. The
functional profile for a bacterial strain was created by identifying the total number
TIGRFAM matches to the strain, and subsequently converting these counts to relative
abundances. The functional profile for a bacterial species was created separately for
each cohort. This was computed by first finding the average genome abundance of
each strain within the cohort, weighting the strain functional profiles based on these
proportions, and then aggregating the resulting strain profiles. Each species functional
profile was then CLR-transformed. CLR-transformation is defined as:
clr(x)= �ln

x2
xD
x1
…,ln
…,ln
�
g(x)
g(x)
g(x)

where x is the vector of species abundances within each sample, D is the total
number of species. The geometric mean of vector x is defined as:
𝑔𝑔(𝑥𝑥) = 𝐷𝐷�𝑥𝑥1 × 𝑥𝑥2 × … 𝑥𝑥𝐷𝐷

TIGRFAM functional annotations were obtained from TIGRFAMs_ROLE_LINK
and TIGRFAM_ROLE_NAMES files generated by J. Craig Venter Institute (JCVI)
(ftp://ftp.jcvi.org/pub/data/TIGRFAMs/14.0_Release/).
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Cohort Sample Functional Profiling
A Simplified Annotation Format (SAF) file containing the bacterial chromosomal
coordinates of TIGRFAMS (features) for all reference strains was provided to
FeatureCounts80 (Subread package 2.0.0) to find the total features contained within
sample reads. Counts of features were subsequently length normalized, summed, and
re-normalized (by total) for each sample producing sample functional profiles. Protein
families were grouped by their TIGRFAM role, and their relative abundances were
aggregated and CLR-transformed to generate the cohort functional role profiles (CFRP).
Roles that were a different sign (+/-) in one cohort, when compared to all other cohorts,
were considered different (elevated/reduced).

Construction of Bacterial Association Networks
For each cohort, a sample-taxa matrix was constructed containing the relative
abundances of the signature species in each sample. The bacterial association network
for a cohort was constructed from its CLR transformed sample-taxa matrix using the
GGM framework. In each case, a sparse precision matrix was computed using the R81
huge82 package, and this matrix formed the adjacency matrix of the association
network. The tuning parameter ρ in the l1-penalty model for sparse precision matrix
estimation was chosen using the stability approach to regularization (StARS) method83.
In order to reduce the number of false positives, the estimated sparse precision matrix
Ω was processed further using a bootstrap method as follows: r bootstrap datasets,
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each with n samples, were generated from the original CLR-transformed matrix by
random sampling with replacement. A sparse precision matrix was estimated from each
bootstrap dataset using the same previously chosen value of the tuning parameter ρ
used to estimate Ω. The final precision matrix Ω’ is derived from Ω as follows: (a) if
Ω[i,j]=0, then Ω’[i,j] = 0. (b) if Ω[i,j] ≠ 0, then Ω’[i,j] = Ω[i,j] if the entry [i,j] is non-zero in at
least f*r precision matrices estimated from the bootstrap datasets. Otherwise Ω’[i,j]=0.
Thus, Ω’ is at least as sparse as Ω. Partial Correlation matrix, P, was calculated as:

𝑃𝑃[𝑖𝑖,𝑗𝑗] =

′
−𝛺𝛺[𝑖𝑖,𝑗𝑗]

′
′
× 𝛺𝛺[𝑗𝑗,𝑗𝑗]
�𝛺𝛺[𝑖𝑖,𝑖𝑖]

The value f is a preset threshold (0 ≤ f ≤ 1). We used r = 50 (bootstrap replicates)
and f = 0.8 (e.g. association must be non-zero >80% of the time) in our analysis. Partial
correlation matrices were parsed using python and all associations below a magnitude
of .01 were considered statistical noise and removed.

Network Property, Clique, and Module Analysis
For each cohort network, the following properties were computed using
NetworkX84 (version 2.4): average shortest path length (ASPL), transitivity, modularity,
degree assortativity, degree centrality, betweenness centrality, and genera assortativity.
The ASPL (α) is defined as:
𝛼𝛼 = 𝛴𝛴𝑠𝑠,𝑡𝑡∈𝑉𝑉

𝐷𝐷[𝑠𝑠, 𝑡𝑡]
𝑛𝑛(𝑛𝑛 − 1)
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where V is the set of nodes in the graph (G), D[s,t] is the shortest path from s to t,
and n is the total number of nodes in G (11,12). The transitivity (T) of a network is the
fraction of all possible triangles present in the graph, and is defined as:
𝑇𝑇 = 3

𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡

triangles are a clique (a subset of nodes within a network where each node is
adjacent to all other nodes within the subset) of three nodes, and triads are the count of
connected triples (three nodes xyz with edges (x,y) and (y,z) where the edge (x,z) can
be present or absent)84,85. Modularity (Q) is defined as:
𝑄𝑄 =

1
𝛴𝛴
𝑘𝑘𝑖𝑖 𝑘𝑘𝑗𝑗
�𝛿𝛿�𝐶𝐶𝑖𝑖 ,𝐶𝐶𝑗𝑗 �
2𝑚𝑚 𝑖𝑖,𝑗𝑗 ∑𝑖𝑖,𝑗𝑗�𝐴𝐴[𝑖𝑖,𝑗𝑗]− 2𝑚𝑚

where A is the adjacency matrix of graph (G), m is the total number of edges, ki is
the degree of node i, and δ(Ci,Cj) is 1 if i and j (node pair) are in the same community or
0 if in different communities85,86. Assortative mixing is a predilection of nodes to form
connections with other nodes that are like (assortative) or unlike (disassortative)
themselves. We measured node mixing preference according to node degree (degree
assortativity) and node genus classification (genera assortativity). Degree assortativity
is calculated using the standard Pearson correlation coefficient:

𝑟𝑟 =

∑𝑥𝑥𝑥𝑥 𝑥𝑥 𝑦𝑦�𝐷𝐷[𝑥𝑥, 𝑦𝑦] − 𝑎𝑎𝑥𝑥 𝑏𝑏𝑦𝑦 �
𝜎𝜎𝑎𝑎 𝜎𝜎𝑏𝑏

Where D is the joint probability distribution matrix, D[x,y] is the fraction of all
edges in the graph that connects nodes with degree values x and y, ax and by are the
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fraction of edges that start and end at nodes with values x and y, and σa and σb are the
standard deviations of the distributions ax and by. The value of r can be any value
between –1 (perfect disassortativity) and 1 (perfect assortativity)(14). Genera
assortativity is defined as:
𝑇𝑇𝑇𝑇𝑇𝑇 − ‖𝑄𝑄2 ‖
𝑟𝑟 =
1 − ‖𝑄𝑄2 ‖

Where Q is the joint probability distribution matrix whose elements are Q[i,j] (the
fraction of all edges in the graph that connects nodes of genus type i to genus type j), Tr
is the trace of the matrix Q, and ||Q|| signifies the sum of all elements of the matrix Q87.
Modules within each network were found utilizing the
label_propogation_communities algorithm, based on the asynchronous label
propagation algorithm (aLPA)42 from NetworkX. To quantify the ability of the aLPA to
partition the data, we utilized the performance function NetworkX. Performance (p) is
defined as:
𝑝𝑝 =

𝑎𝑎 + 𝑏𝑏
𝑐𝑐

where a is the total intra-module edges, b is the total inter-module non-edges,
and c is the total potential edges89. Monte Carlo simulations were utilized to test for
statistical significance of network property differences (see supplemental). Three
member cliques and modules within each network were found using NetworkX. Module
functional profiles (MFP) were created by aggregating the functional profiles of species
contained within each module.
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Network Node Centrality Analysis
Degree centrality is defined as the degree (total edges) of a node. The node
within each network module exhibiting the highest degree centrality was designated as
a module “hub”. If two or more species were found to have equal degree centrality then
centrality measurements of those nodes were re-computed in context of the entire
network. The top ten nodes exhibiting the highest betweenness centrality within each
network were designated as “bottlenecks”. To find “bottleneck” species, betweenness
centrality was computed for each node. Betweenness centrality is defined as:
𝐶𝐶𝐵𝐵 (𝑢𝑢) = �

𝑠𝑠,𝑡𝑡∈𝑉𝑉

𝜎𝜎(𝑠𝑠, 𝑡𝑡|𝑢𝑢)
𝜎𝜎(𝑠𝑠, 𝑡𝑡)

where the betweenness centrality of a node (υ) is the sum of the fraction of allpairs shortest paths that pass through υ, V is the set of all nodes, σ(s,t) is the number of
shortest paths (s,t)-paths, and σ(s,t| υ) is the number of those paths passing through
node υ other than s,t90.
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Figures

Figure 1: ‘Abundant cores’ and Signature Species.
a. All cohorts exhibit a bimodal distribution for species prevalence. Species that are prevalent in
90% or more samples within a cohort is considered a member of that cohort’s ‘abundant core’.
b. The proportion of total sample relative abundance each cohort’s ‘abundant core’ species and
the union of all ‘abundant cores’ species (i.e. Signature Species/Sig). The ‘abundant core’
microbiota is shown to account for the bulk of reads mapped within each sample. Each dot
represents a sample from that cohort. c. PCA demonstrating the lack of distinct clustering of
samples from different cohorts based on CLR-transformed relative abundance data of the
signature species. Samples from the Indian and American cohorts appear to separate from the
rest of the cohorts however, samples from the other two cohorts demonstrate little separation.
The diamonds indicate cluster centroids.
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a.
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b.

Figure 2: Effect of prevalence thresholds on RFC accuracy.
a. The 90% bacterial prevalence threshold enables the most accurate distinction between cohorts. Bacterial species used for RFC-based classification were determined by prevalence of
bacteria in the samples. The 90% prevalence threshold offers slightly better ability to distinguish between the cohorts based on their taxonomic profiles while removing over 1,800 features. The 90% prevalence threshold was then randomly permuted (RandPermute) and added to
the plot as a reference. Utilizing only species that were present in 100% of samples led to diminished accuracy while removing relatively few features. b. Multi-class Receiver Operator
Characteristic (mROC) graph was created for each cohort. Each cohort displayed a large Area
Under the Curve (AUC) indicating that the model was able to accurately distinguish the different cohorts from each other using the taxonomic profiles alone. The multi-class AUC was
weighted by sample size for each cohort.
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a.
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b.

Figure 3: GGM algorithm benchmarking
Average F1-scores of the GGM algorithm for various graph-types and sample-to-taxa ratios.
Synthetic data was modeled on the CLR-transformed means and sample-to-taxa ratios present in
the real data sets. A sample-to-taxa ratio of 10 was added to demon-strate the effect adding
additional samples has on accuracy of GGM. a. The average F1-score for all graph-types is
0.74. The hub and band networks consistently exhibit the highest accuracy. An overt increase in
accuracy is demonstrated as the sample-to-taxa ratio increases for all graph-types, with no
graph-type have an F1-score <0.9 at a sam-ple-to-taxa ratio of 10. b. GGM consistently
underestimates magnitude of associations. As sample-to-taxa ratio increases, there is an
appreciable increase in the accuracy of association magnitude estimation in all, but the cluster
and scale-free, graph-types.
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Figure 4: Species-level bacterial association networks by cohort.
Network modeling of associations between (173/202) signature species within each network. A
total of 29 species were not shown as they had zero edges in all networks. Node color designates
the phylum each species belongs to, node size is reflective of node degree, and edge color
represents if the association is positive (green) or negative (red). Nodes are ordered
counterclockwise around the circle by the alphabetical order of the concatenated string of all
taxonomic levels. Nodes that are numbered correspond to species with the highest degree
centrality within modules, designated as “hubs”. Brackets around [Bacteroides] pectinophilus
indicate that it is misclassified (i.e. placed incorrectly in a higher taxonomic rank and awaiting
to be formally renamed). We utilized Blast to designate [Bacteroides] pectinophilus as belonging
to the phylum Firmicutes91. For a full list of species shown and not shown within network
models see supplemental.
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Figure 5: Cohort network association analysis.
a. The distribution of bacterial association weights within each cohort’s network, dots and (n)
represent total associations. b. The proportion of associations within each cohort’s network that
are unique (red) or shared (blue) with at least one other network. c. Sub-graph displaying only
the 20 conserved nodes (species) and 14 edges (associations) retained across all cohorts.
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Figure 6: Conserved genera counts.
When examining the networks of all cohorts, there were 14 conserved associations comprised of
20 bacterial species. Species of the Bacteroides genus were the most abundant constituents of the
bacterial associations conserved within all cohorts.
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Figure 7: Cohort negative association heatmap.
Heatmaps of the proportion of total negative associations within each cohort’s network that
order member species were found to be involved in. Within each cohort, negative associations
appear to occur mainly between species from the order Clostridiales.
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Figure 8: Taxonomic and functional relationships between species.
a. Proportion of associations within each cohort’s network that are either positive or negative at
the lowest level of taxonomic relation (n = total associations). Most positive associations appear
between taxonomically similar species. b. Association weight vs Bray-Curtis distance of genome
functional profiles between network partners. Positive associations between functionally similar
species are both common and greater in strength than negative associations. There appears to be
a minimal distance between genome functional profiles before a negative association is
demonstrated. c. An asynchronous LPA was used to analyze the modules composing the
networks of each cohort. Four distinct clusters were found, and each cohort was represented
within each cluster. The American cohort appears to be biased towards the Cluster IV, however
the other cohorts do not appear overtly biased to any one cluster. Each dot represents the
aggregated TIGRFAM profiles of an individual module found by aLPA and the diamonds
represent the cohort centroids.
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Figure 9: Genera involvement in clique formation as a percentage.
Heatmap of the proportion of total cliques found within each cohort’s network that genera
member species were found to be involved in (n = total 3 member cliques). Species from the
genus Bacteroides tend to be found in the majority of cliques across all cohorts.

47

Figure 10: Proportion of genera shared in cliques.
Heatmap of cliques that were retained in at least one other network. Cliques that Bacteroides sp.
are involved in are highly re-tained across networks.
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Figure 11: Distribution of module sizes.
Distribution of module sizes found by asynchronous LPA, colored by cohort. a. Distribution of
module sizes within the European cohort. b. Distribution of module sizes within the American
cohort. c. Distribution of module sizes within the Indian cohort. d. Distribution of module sizes
within the Japanese cohort.
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Figure 12: Pie charts of cluster taxonomy.
Pie plots demonstrating genus-level taxonomic compositions within each of the module clusters.
Clusters were determined using PCA of module functional profiles for each module. a. Cluster I
is dominated by members of the Streptococcus and Bifidobacterium genera and no genus
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represents less than 3% relative abundance. b. Members of the Bacteroides genus are the most
abundant in the Cluster III and there are 49 genera with relative abundances below 3%. c.
Members of the Bacteroides genus are also the most abundant in the Cluster II, however the
Prevotella and Allistipes genera are also abundant and account for >70% of abundance when
combined with Bacteroides. There are 6 genera with relative abundances below 3%. d. There are
only 5 genera above 3% relative abundance and 44 genera below 3% with no one genus showing
greater than 15% relative abundance. Genera with < 3% relative abundance were placed in the
‘Others’ category.
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Figure 13: Functional role profile differences.
Tables illustrating relative differences in functional roles within the cohorts. Roles that were
different signs (+/-) in one cohort relative to all other cohorts, were deemed different. If the sign
was negative after CLR transformation, the role was considered reduced and if the sign was
positive the role is considered elevated a. The different clusters ap-pear to have overt functional
differences possibly indicating the importance of the existence of modules from each cluster in a
cohort for the healthy functioning of the gut microbiome.
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Figure 14: Cohort functional profile PCA.
PCA was performed by analyzing the aggregated cohort functional profiles of each cohort. The
cohorts have a large amount of overlap and do not appear to distinctly separate.
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Figure 15: Cohort functional profiles.
Few functional role differences were demonstrated between the different cohorts as only the
American and European cohorts had more than one difference and only the European cohort
demonstrated greater than two differences.
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Figure 16: Degree assortativity of modules.
Distribution of the degree assortativity of modules within cohort networks. Most modules were
disassortative in respect to their degree assortativity hinting at "hub" species existing within
modules.
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a.
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b.

Figure 17: Cohort network “hubs” and “bottlenecks”
a. Species with highest degree centrality are designated as “hubs.” b. Species with highest
betweenness centrality are designated as “bottlenecks.”
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Figure 18: Sample counts in each cohort.
A bar plot representing the counts of samples from each cohort.
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Figure 19: Read statistics by cohort.
a. Each dot represents the total reads in an individual sample. The dashed black line in each
box-plot represents the median reads of the cohort. b. Each dot represents the mapped reads in
an individual sample. The dashed black line in each box-plot represents the median mapped
reads of the cohort. c. Each dot represents the percent mapped reads in an individual sample.
The dashed black line in each box-plot represents the median percent of reads mapped for each
cohort.
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Figure 20: EM benchmarking on simulated bacterial communities.
Stacked bar graphs showing benchmarking results of our EM algorithm on estimating known
genome relative abundances from simulated whole-genome shotgun sequences created with
WGSim; a. strain level results of a mixed E. coli community with Pearson's R2 = 0.997 between
known genome relative abundances and the EM genome relative abundance estimations; b.
species level results of a mixed community with a Pearson's R2 = 0.999 between the known
genome relative abundances and the EM genome rela-tive abundance estimations.
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Figure 21:Read-depth benchmarking.
Correlation of varying read depths with samples at 5+ million read depth. Samples with 5+
million reads were sub-sampled to varying depths and examined using ordinary least squares
linear regression. Samples with 250 000+ reads, on average, demonstrate an R2 value greater
than 0.85. The red text indicated the chosen threshold for subsequent analysis.
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Figure 22: Reference genome completeness estimation.
All reference genomes utilized for read mapping were analyzed for their percentage of genome
completeness with CheckM. In total there were 10 839 genomes of which only 38 (0.004%) that
were designated as below 70% complete. One genome was marked as 0.0% complete although
that was due to CheckM not having data on the lineage of that organism.
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Tables
Table 1: Cohort network topological properties.
Network topological properties calculated for each cohort’s network. The plus (+) or minus (-)
sign indicates that the network property was greater or lower than the average of 1,000 random
networks. Stars indicate that the network property was statistically significantly different (Pvalue: * < 0.05, ** <0.01, ***<0.001).
Network

Nodes

Edges

Density

ASPL

Transitivity

Modularity

American
Indian
European
Japanese

202
202
202
202

338
273
386
274

0.017
0.013
0.019
0.013

1.539
1.874
1.369
1.444

0.487
0.452
0.353
0.471

0.475
0.667
0.681
0.755

Degree
Assortativity
0.338
0.330
0.158
0.308

Genera
Assortativity
0.144
0.163
0.196
0.242
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CHAPTER 3: LINKING INFLAMMATORY BOWEL DISEASE
SYMPTOMS TO CHANGES IN THE GUT MICROBIOME STRUCURE
AND FUNCTIONS
Note: This section has been published in part and the citation link is: Hassouneh,
S. A. D., Loftus, M., & Yooseph, S. (2021). Linking Inflammatory Bowel Disease
Symptoms to Changes in the Gut Microbiome Structure and Function. Frontiers in
Microbiology, 12, 2009. https://www.frontiersin.org/articles/10.3389/fmicb.2021.673632.

Introduction
Inflammatory bowel disease (IBD) is a heterogeneous disorder characterized by
chronic inflammation of the gastrointestinal tract. The two main manifestations of IBD
are Crohn’s Disease (CD) and Ulcerative Colitis (UC). CD most often affects the
terminal ileum but can affect any part of the gastrointestinal tract in a non-contiguous
fashion, sometimes known as ‘skip lesions’, and often results in diarrhea, bloody stools,
abdominal pain, cachexia, and fatigue (Veauthier and Hornecker 2018; Flores et al.
2015). UC most often affects the large intestine, extending from the rectum, and is
characterized by contiguous inflammation and often results in rectal bleeding, bloody
stools, diarrhea, cachexia, and fatigue (Flores et al. 2015; “FDA Briefing Document
Gastrointestinal Drug Advisory Committee Meeting” 2018). While the etiology of IBD is
not well understood, it is believed that the disorder arises due to environmental and
host-related factors causing an aberrant immune response in genetically predisposed
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individuals (Chiara et al. 2020; Kish et al. 2013). One such factor is believed to be the
microbiome, specifically the gut microbiome (Duranti et al. 2016).

The human microbiome is the community of microbes that exists on and within
the human body and has been implicated in maintaining health, as well as possibly
contributing to a multitude of diseases such as IBD, Irritable Bowel Syndrome (IBS),
diabetes, Parkinson’s disease, and amyotrophic lateral sclerosis (Gevers, Kugathasan,
Denson, Vázquez-Baeza, Van Treuren, et al. 2014; Vich Vila et al. 2018; Brown et al.
2011; Petrov et al. 2017; Wu et al. 2015; Kho and Lal 2018). The bacterial composition
of the microbiome can be studied using DNA sequencing, either by targeted sequencing
of a marker gene or by shotgun sequencing. Targeted sequencing involves the
amplification of specific regions of bacterial genomes, such as the 16S ribosomal RNA
gene, for use as a phylogenetic marker (George E Fox et al. 1977). However, due to the
highly conserved nature of the 16S rRNA gene and the short lengths of the regions
within the gene that are commonly targeted, the taxonomic resolution generated by
these types of studies are often inadequate to distinguish bacterial species (G. E. Fox,
Wisotzkey, and Jurtshuk 1992; Ranjan et al. 2016). Furthermore, estimation of bacterial
relative abundances is confounded by the presence of multiple copies and intragenic
variation of the 16S rRNA gene within a single bacterium (Rastogi et al. 2009; Ibal et al.
2019). In contrast, shotgun sequence data generated from the DNA extracted from a
sample can be used to obtain more accurate estimates of relative abundance, higher
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resolution of bacterial taxonomy, and a more accurate representation of genomic
functional capacity (Ranjan et al. 2016; Laudadio et al. 2018).

Regardless of the sequencing framework used, the generated sequence data are
compositional in nature enabling only an estimation of the relative abundances of the
constituent microbial taxa (Gloor et al. 2017). This compositionality aspect makes it
difficult to analyze differential abundance, infer associations, and estimate correlations
(Aitchison 1982; Jonathan Friedman and Alm 2012; Tsilimigras and Fodor 2016;
Pearson 1896). By utilizing a Centered Log-Ratio (CLR) transformation of the relative
abundance data, we can examine the differential abundances more clearly and without
inducing spurious correlations (Aitchison 1982; Jonathan Friedman and Alm 2012;
Tsilimigras and Fodor 2016; Pearson 1896). Furthermore, the covariance matrix of logtransformed relative abundance data provides a good approximation of the covariance
matrix of the log-transformed absolute abundance data enabling us to better model the
associations between bacteria (Kurtz et al. 2015).

Associations within a bacterial community are comprised of the direct and
indirect interactions between the community constituents and are important for
understanding the underlying dynamics at play in a microbial community (Kurtz et al.
2015). Bacterial association networks are often constructed using pairwise correlation
methods on relative abundance or count data of the bacteria found within the samples.
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Due to the compositional nature of sequencing data, however, it is difficult to accurately
identify correlations from counts generated from sequencing data as a result of spurious
correlations that arise (Jonathan Friedman and Alm 2012). Even after CLRtransformation of the sequencing data, pairwise correlation methods are unable to
account for conditional independence between bacterial species causing these methods
to produce inaccurate bacterial association networks (Kurtz et al. 2015). In this paper,
we used a Gaussian Graphical Model (GGM) framework in conjunction with a graphical
lasso (glasso) to construct bacterial association networks from the CLR-transformed
relative abundance data (Jerome Friedman, Hastie, and Tibshirani 2008; Loftus,
Hassouneh, and Yooseph 2021). We represent these bacterial association networks
using an unweighted graph in which nodes denote bacterial species and an edge
between two nodes denotes an association between the corresponding bacterial
species. Utilizing the GGM framework on the CLR-transformed data, enables us to
approximate the covariance structure of the absolute abundances as well as account for
conditional independence between the constituent species (Wermuth and Lauritzen
1990; Aitchison 1982). By utilizing shotgun sequence data and employing
compositionally robust methodologies, we can identify potentially important differences
in bacterial associations, taxonomic composition, and functional capacity between the
IBD and healthy gut microbiomes that may play a role in disease and symptom
progression.
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Due to the Random Forest Classifier’s (RFC) ability to deal with ’noisy’, nonnormally distributed, multi-dimensional data, it has become an important tool for
identifying important features and differences in the microbiome (Breiman 2001; DíazUriarte and Alvarez de Andrés 2006; Loomba et al. 2017; Saulnier et al. 2011; Roguet
et al. 2018; Shi et al. 2005). These features can include bacterial relative abundances
and metadata thus allowing us to generate a model that accounts for subject
characteristics as well as gut microbiome taxonomic profiles. Another benefit of the RFC
is its ability to assign importance to the features used for the classification. The feature
importance’s allow us to quantify the role a specific feature plays in making a prediction
and can allow us to determine which features may be informative. One shortcoming of
these feature importances, however, is their lack of statistical significance. Due to the
stochastic nature of model construction using an RFC, some features may be relatively
important in one instance of an RFC model, but relatively unimportant in another
instance of the RFC model. To enable us to utilize RFC feature importance to
distinguish potentially important features and reduce the dimensionality of our data, we
formulated a framework that allowed us to add statistical significance to the feature
importances.

Here, we utilized the IBD Multi-omics DataBase (IBDMDB) cohort from a
previously published study to study IBD (Lloyd-Price et al. 2019). This dataset consists
of shotgun sequence data generated from CD, UC, and an internal control group
(henceforth also referred to as non-IBD samples). The non-IBD samples were collected
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from subjects that underwent histopathologic examination (via colonoscopy) but were
not diagnosed with IBD. These samples are derived from subjects presenting for routine
screenings, gastrointestinal (GI) distress, or non-specific symptoms generating a
heterogeneous control group. This control group design may obfuscate important
differences between healthy and IBD gut microbiomes, especially if the differences may
be related to presentations common between IBD and GI distress, such as diarrhea,
bloating, or abdominal pain. Additionally, many studies examining the microbiome suffer
from a lack of cross-cohort consistency making it difficult to generalize findings to
populations rather than just the utilized study groups (Pasolli et al. 2016). One proposed
remedy for this lack of cross-cohort consistency is to utilize external samples from
independent cohorts, especially when comparing diseased and healthy microbiomes,
and applying the same methods and techniques across all samples (Pasolli et al. 2016;
Thomas et al. 2019). To enable us to generalize our findings and utilize healthy control
groups in our analysis, we incorporated samples from both the Human Microbiome
Project (Huttenhower et al. 2012) referred to as the Healthy-1 cohort, and from A.J.
Johnson et al 2019 (Johnson et al. 2019) referred to as the Healthy-2 cohort, as
external controls. The external cohorts we elected to use were shotgun sequence
datasets generated from gut microbiome samples collected from healthy subjects (no
overt or reported disease) and utilizing the same sequencing platform as the IBDMDB
cohort (Illumina). Furthermore, due to the similarity of the results produced by the
Chemagic DNA extraction kit (IBDMDB cohort) and the Mo Bio PowerSoil DNA
extraction kit (Healthy-1 and Healthy-2 cohorts), we concluded that these cohorts could
serve as external controls without the addition of a significant amount of technical bias
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(Multinu et al. 2018). Also, due to the use of replicates within the Healthy-2 cohort and
the IBDMDB cohort, we were able to examine temporal variation within subjects
diagnosed with IBD relative to the non-IBD group (internal control) and the Healthy-2
group (external control). By incorporating these two independent healthy cohorts, we
can compare the IBD samples to healthy samples and mitigate the possible issues
inherent in the design of the IBDMDB internal control group (non-IBD group) as well as
arrive at more robust and generalizable conclusions from our analysis.

To understand the effects of changes in the microbiome, we cannot solely focus
on the presence, absence, or differential abundances that are found. We also need to
examine how these bacteria interact with each other to understand the impacts they
have on shaping the microbiome. It is also integral that we examine the functional
consequences of these differences and associations to build a more complete picture of
the changes the gut microbiome underwent and the possible effects these changes may
foment (Heintz-Buschart and Wilmes 2018). By examining the taxonomy, the bacterial
interactions, and the functional changes of the gut microbiome, our study aims to
identify bacterial species that may play a role in the onset or exacerbation of IBD or
IBD-related symptoms. By utilizing two external healthy controls, we are also able to
corroborate our conclusions when comparing IBD and healthy samples and generalize
our findings more confidently to the population. Additionally, we utilized a machine
learning framework and a prevalence threshold to identify potentially important bacterial
species. We also compared the functional capacity of the gut microbiome of IBD
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samples to non-IBD and control samples, and identified important potential functional
differences that may play a role in symptoms IBD patients typically experience.

Materials and Methods
Data Acquisition

Shotgun sequence data generated from 574 fecal samples were obtained from
three previously published studies of the human gut microbiome (United States
populations). Of these, two cohorts were downloaded from NCBI’s Sequence Read
Archive (SRA): Human Microbiome Project (SRA: PRJNA48479; 203 samples) and the
IBD Multi-omics Database (SRA: PRJNA398089; 257 samples). The A.J. Johnson et al
cohort was downloaded from the European Nucleotide Archive (ENA) (ENA:
PRJEB29065; 114 samples). We were able to access metadata for sex and age/agegroup for all cohorts.

Data pre-processing

Reads from the whole genome sequencing data were trimmed using
Trimmomatic (version 0.36) and then reads corresponding to the human genome were
filtered out using BowTie2 (version 5.4.0) and the GRCh38.p12
(www.ncbi.nlm.nih.gov/assembly/GCF_000001405.38) human reference genome
(Bolger, Lohse, and Usadel 2014; Langmead and Salzberg 2012).
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Read mapping and taxonomic identification

Reads were mapped to 10,839 bacterial reference strain genomes obtained from
the NCBI RefSeq database using BowTie2 (O’Leary et al. 2016). Bacterial genome
relative abundances were estimated using a probabilistic framework based on a mixture
model. The framework utilized an Expectation-Maximization (EM) algorithm to perform
soft assignment of the reads to the reference genomes and was found to be highly
accurate (Xia et al. 2011; Loftus, Hassouneh, and Yooseph 2021). We have previously
demonstrated that samples with less than 250,000 mapped reads display diminished
accuracy for taxonomic profiling, consequently all samples that contained less than
250,000 mapped reads threshold were not used for downstream analysis (Loftus,
Hassouneh, and Yooseph 2021). When calculating abundances, any strain that had a
relative abundance below 1 × 10−5 was considered statistical noise. The relative

abundance data was then transformed using the CLR transformation and the CLRtransformed data was used for all downstream analyses except for the alpha-diversity
analysis. The CLR transformation is defined as:
𝐶𝐶𝐶𝐶𝐶𝐶(𝑥𝑥) = �𝑙𝑙𝑙𝑙
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where x is the vector of relative abundances within a sample, D is the total
number of species present within the sample, and G(x) is the geometric mean of x. The
geometric mean is defined as:
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Sample inclusion criteria

IBDMDB inclusion criteria
To reduce potential confounders within the internal control group (non-IBD
samples), we instituted a set of inclusion criteria for the non-IBD group: no colonoscopy
within the last two weeks, no history of bowel surgery, no immunosuppressants use, no
antibiotic use, no IBS, and no diarrhea in the past two weeks. Due to the adverse
associations between these variables and the gut microbiome that have been noted in
the literature, we excluded any samples from subjects that violated these criteria
(Schubert et al. 2014; Halfvarson et al. 2017; Bhat et al. 2017; Dethlefsen et al. 2008;
Vich Vila et al. 2018; Nagata et al. 2019). We also did not utilize any samples collected
prior to week 26 of the study to ensure that subjects had ample time to overcome any
gastrointestinal distress they have been experiencing at the time of study initiation. To
limit any potential bias from an over-representation of a subject within the cohort, no
more than five randomly chosen samples were retained from any one subject for any of
the sample groups in the IBDMDB cohort (CD, UC, non-IBD) resulting in a mean
number of replicates of 2.5 and a median of 2.
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Healthy-1 cohort inclusion criteria
Samples for the healthy-1 cohort were derived from (Huttenhower et al. 2012)
and were generated as part of the Human Microbiome Project. All 203 samples utilized
were derived from unique individuals and demonstrated over 250,000 mapped reads so
all samples were included in the analysis.

Healthy-2 cohort inclusion criteria
Samples for the healthy-2 cohort were derived from (Johnson et al. 2019) and
were generated as part of a longitudinal analysis of fecal shotgun metagenomes in
healthy subjects. The study by Johnson et al aimed to examine gut microbiome
responses to a changes diet. Subject were randomly given fatty acid supplementation
on days 10-17 of the study. To ensure that our analysis reflected healthy samples on
habitual diets, only samples taken prior to day 10 of the study were used. Furthermore,
subjects were sampled daily for 17 days but not all subjects consistently had more than
five samples with greater than 250,000 (minimum threshold for inclusion) mapped reads
so to limit the number of replicates from a single subject a maximum of five randomly
chosen samples were retained from any one subject resulting in a mean number of
replicates of 3.3 and a median of 3.

Diversity analysis
Alpha diversity was analyzed using the Shannon entropy. The Shannon entropy,
H, is defined as:
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where D is the number of species in the sample and pi is the proportion of
species i in the sample (Shannon 1948). The non-transformed relative abundances
were used for the Shannon entropy calculations.

Intrapersonal and interpersonal dissimilarity
The Bray-Curtis dissimilarity (BCD) between replicates within a subject was used
to quantify intrapersonal variation within each cohort with replicates (IBDMDB and
Healthy-2 cohorts). The BCD between subjects within diagnosis groups (interpersonal
dissimilarity) was also examined to observe the variability of the gut microbiome within
the diagnosis groups. The BCD between two samples, i and j, was calculated as
𝐵𝐵𝐵𝐵𝐵𝐵𝑖𝑖,𝑗𝑗 = 1 −

2𝐶𝐶𝑖𝑖𝑖𝑖
𝑆𝑆𝑖𝑖 + 𝑆𝑆𝑗𝑗

where Cij is the sum of the relative abundances of the species with the lowest
combined relative abundance within samples i and j. Si and Sj are the sums of the
relative abundances found in sample i and sample j, respectively. The intrapersonal
dissimilarity was calculated by generating pairwise BCD’s for samples from the same
subject. The interpersonal dissimilarity was calculated by generating pairwise BCD’s
between samples from different subjects.
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Prevalent species
To reduce the dimensionality of our data, we utilized only bacterial species that
were present in at least 90% of samples within each diagnosis group (IBD, non-IBD,
Healthy-1, and Healthy-2) for our downstream analysis (Loftus, Hassouneh, and
Yooseph 2021). The union of the bacterial species present at a prevalence greater than
or equal to 90% in each diagnosis group was then used for the classification of the
signature species.

Classification of signature species
A modified Random Forest Classifier (RFC) framework was used to identify
bacterial species for downstream analysis (Breiman 2001). The RFC was used to
classify samples by the sample groups (IBD, non-IBD, and Healthy). The Healthy-1 and
Healthy-2 cohort were combined for the RFC analysis to enable us to identify bacterial
species importances by health status, rather than by cohort. A random noise column
was added into the data prior to RFC analysis. The noise column was generated by
creating a normal distribution resembling the CLR-transformed data of the genome
relative abundances and randomly sampling from the distribution. The data was then
label encoded due to the presence of categorical data. This process was performed 100
times, where a new random noise column would be generated each time, and the
feature importances of every feature (bacterial species, metadata, and the random
feature) were stored for all runs. A Mann-Whitney U test was then performed on the
importances of all features with a mean feature importance higher than the random
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feature to determine if the importances of these features were significantly different from
the feature importances of the random column. The Benjamini-Hochberg procedure for
controlling false discovery rate was utilized to account for the multiple-testing and only
features with a q-values less than 0.05 were considered significantly different from the
random column (Benjamini and Hochberg 1995). This framework allows us to identify
the bacterial species and metadata whose feature importances were significantly higher
than the random noise. The bacterial species that were significantly more important
than the random noise column are referred to as the ‘signature’ species due to their
ability to provide a non-random signal during classification. The RFC was implemented
in Python 3.8 using Sci-kit Learn 0.23.1 (Van Rossum, Guido and Drake 2009;
Varoquaux et al. 2015).

Differential abundance analysis
Differential abundance analysis was conducted by performing a Mann-Whitney U
test and the Benjamini-Hochberg multi-test correction on the CLR-transformed relative
abundance profiles. The IBD group was compared to the non-IBD group, the Healthy-1
group, and the Healthy-2 group individually. Bacterial species that were significantly
differentially abundant in IBD relative to every other individual group were designated as
differentially abundant.
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Bacterial association network construction
The signature species were used to create a sample-taxa matrix of CLRtransformed relative abundances in each sample. The GGM framework, as previously
described, was used to generate the bacterial association networks using the above
sample-taxa matrices for each cohort (Loftus, Hassouneh, and Yooseph 2021). In brief,
the HUGE package in R was used to compute a sparse precision matrix. The stability
approach to regularization selection (StARS) method was used to determine the tuning
parameter in the l1-penalty model for sparse precision matrix estimation. To reduce false
positives, the final precision matrix, Ω, underwent bootstrap testing. If Ω[i,j] ≠ 0, then
Ω’[i,j] = Ω[i,j] if[𝑖𝑖, 𝑗𝑗] ≠ 0 in f*r or greater precision matrices estimated from bootstraping.
Otherwise, Ω’[i,j]=0. The value r = 50 (bootstrap replicates) and f = 0.8 (threshold

between 0 and 1 indicating proportion of edges that must be non-zero). Networks were
visualized and analyzed using Python 3.8 and NetworkX 2.4 (Hagberg, Schult, and
Swart 2008).

Eigenvector centrality
Eigenvector centrality (EVC) measures the influence a node has in a network by
accounting for the connections of the node in question as well as the connections of its
neighbors (Bonacich 1972; Ruhnau 2000). The EVC, x, for a given node, i, is defined
as:
𝑥𝑥𝑖𝑖 = � 𝐴𝐴𝑖𝑖𝑖𝑖 𝑥𝑥𝑗𝑗
𝑗𝑗
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where A is the adjacency matrix and j is a neighboring node of i.

Bacterial genome functional annotation
Prodigal (version 2.6.3) was used to identify genes and generate protein
sequence translations (Hyatt et al. 2010). The protein sequence translations were
provided to InterProScan (version 5.39-77.0) to identify protein families using the
TIGRFAM (versions 15.0) protein family database (Hunter et al. 2009; Haft 2001).
TIGRFAM counts were generated for each reference genome. Bacterial species that
were greater than 90% prevalent within a diagnosis group (IBD, non-IBD, Healthy-1,
and Healthy-2) were used for functional annotation to reduce the effects of potentially
transient species when analyzing the genomic functional capacity of the microbiomes
(Saunders et al. 2016; Ursell et al. 2012). Then the TIGRFAM counts were weighted
based on CLR-transformed genome relative abundance, and summed by total for each
cohort. Differential abundances of TIGRFAM profiles were therefore calculated by using
the CLR-transformed relative abundances of the TIGRFAMs within each cohort. The
TIGRFAM CLR-transformed relative abundances were then tested using a MannWhitney U test.

Statistical analysis and graph creation
Statistical analysis and graph creation was performed using Python 3.8 (Van
Rossum, Guido and Drake 2009).
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Results
A total of 569 shotgun sequence datasets from 3 previously published studies
(IBDMDB, Healthy-1, and Healthy-2) of the human gut microbiome were utilized in this
study. The IBDMDB cohort consisted of CD, UC, and non-IBD samples. To minimize
potential confounders in the IBDMDB group, samples from individuals that reported
recent colonoscopy, antibiotic or immunosuppressant use, IBS, or recent GI symptoms
were excluded from the control (non-IBD) group. For each dataset, the sequence reads
were quality trimmed and human reads were identified and filtered. The remaining reads
were mapped to a comprehensive collection of 10,839 bacterial strain reference
genomes from NCBI RefSeq and genome relative abundances were calculated using a
probabilistic framework (Xia et al. 2011; Loftus, Hassouneh, and Yooseph 2021). The
alpha-diversity was then calculated on the relative abundances using Shannon entropy.
To reduce the dimensionality of our data, we focused our analysis on bacterial species
that were prevalent in at least 90% of the samples. Next, the relative abundance vector
for each sample was CLR transformed and used for all downstream analysis. A random
forest classifier (RFC) framework (Breiman 2001) was then used to classify the samples
by their diagnosis groups using the taxonomic profiles as well as the metadata available
for all cohorts (sex, age, unique subject ID to account for replicates). For the RFC
analysis, the Healthy-1 and Healthy-2 cohorts were grouped under one label (Healthy)
to create a single healthy control group to compare to the IBD and non-IBD sample
groups thus allowing us to identify important features that distinguish between diagnosis
groups rather than cohort in a more robust manner (Pasolli et al. 2016; Thomas et al.
2019). The RFC was then trained on the taxonomic profiles as well as the metadata
87

available for all cohorts. While RFC’s provide feature importances based on the
features’ contribution to classification of the given label, there is no statistical
significance attached to these importances. To assess statistical significance of the
features a random noise column was generated and added to the data (see methods).
The species that were ranked as significantly more important than the random noise
column were designated as the ‘signature species’ and used for all downstream
analyses. A Mann-Whitney U test and Benjamini-Hochberg (BH) multi-test correction
was used to compare the differential abundance of the signature species within IBD to
all other groups individually.
Bacterial species that were significantly differentially abundant in IBD, relative to
every other sample group, were designated as differentially abundant. Next, a GGM
framework (see methods) was used to construct the bacterial association networks from
the relative abundance information of each sample group. Finally, the genomic
functional capacity within each sample group was determined by using the TIGRFAM
protein family database. The TIGRFAM counts for each signature species were
weighted by the relative abundance of the species within each sample group and then
CLR-transformed. A Mann-Whitney U test and BH multi-test correction was then used to
compare the differential abundance of the TIGRFAM functions within IBD to the other
groups to determine differences in functional capacity.
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Alpha-diversity analysis
The non-IBD group displayed a similar alpha-diversity to the UC and CD groups,
however the external healthy cohorts displayed significantly higher alpha-diversities
than all other groups (Figure 23). When examining the effect of cohort read-depth on
alpha-diversity, we did not observe any significant correlation between read-depth and
alpha-diversity (Figure 24). Notably, the Healthy-2 cohort displayed lower read-depth
on average, relative to the IBDMDB cohort, but displayed significantly higher alphadiversity.

Intrapersonal dissimilarity
When examining intrapersonal dissimilarity, it was noted that samples from the
same subject were significantly more similar to each other than they were to samples
from other subjects (Figure 25a). This trend was constant for every diagnosis group
that could be tested (Healthy-1 cohort did not utilize replicates) and was statistically
significant every time. Furthermore, it was observed that IBD samples demonstrated the
highest levels of intrapersonal dissimilarity and were significantly higher than both nonIBD samples and Healthy-2 samples. Interestingly, the intrapersonal dissimilarity of nonIBD samples fell between the IBD and the Healthy-2 samples.

Interpersonal dissimilarity
To quantify how different the gut microbiomes of samples within a specific
diagnosis group are, we examined the interpersonal dissimilarity. Once again, the IBD
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samples exhibited the highest levels of dissimilarity when examining the interpersonal
dissimilarity (Figure 25b). IBD sample interpersonal dissimilarities were significantly
higher than the Healthy-1 and Healthy-2 samples but were not significantly different
than the non-IBD samples. It was also noted that the non-IBD samples displayed
significantly higher interpersonal dissimilarity, relative to the Healthy-1 and Healthy-2
cohorts.

Taxonomic analysis
When attempting to classify all different diagnoses (CD, UC, non-IBD, and
healthy) using the RFC, it was noted that CD and UC samples were often misclassified
as one another (CD as UC or vice versa) which contributed to the modest RFC
classification accuracy (weighted average F1-score: 0.79) (Figure 26a). After combining
the CD and UC diagnoses into the IBD sample group, the RFC was able to distinguish
between the various cohorts with higher average accuracy (weighted average F1-score:
0.87) (Figure 27). Notably, the non-IBD group was difficult to distinguish, and these
misclassifications were split between IBD and healthy controls implying that the non-IBD
group had a heterogeneous composition in which some samples resembled healthy
samples and others resembled IBD samples (Figure 26b). The RFC model identified
122 important features with the ‘age’ feature demonstrating the greatest feature
importance. The ‘unique subject ID’ feature was also an important feature but was
ranked 99/122 according to feature importance. The remaining 120 important features
were bacterial species. The CLR-transformed relative abundances of these 120 species
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were then compared between IBD and non-IBD (internal control) resulting in 55
significantly differentially abundance species. Out of these 55 species, 42 were
significantly differentially abundant in IBD relative to all three control groups (non-IBD,
Healthy-1 Healthy-2) with a q-value < 0.05 and greater than a two-fold difference
(Figure 28). Of those 42 species, 34 were elevated in IBD and 8 species were elevated
in the internal and external controls. All 42 of the above species were also found to be
differentially abundant when utilizing the union of the 90% prevalent species for the
differential abundance analysis. Out of the 34 species elevated in IBD, only the
Clostridium (5 species) and Blautia (4 species) genera displayed more than 2 species
elevated (Figure 29).

Bacterial association networks
Bacterial species elevated in IBD had non-zero degree in all bacterial association
networks (Figure 30). While these nodes were elevated in IBD, they still maintained a
higher than average number of associations within all networks (Figure 31). It was
observed that while the nodes elevated in IBD display higher than average degree, the
majority of nodes within each network were actually composed of species that were not
significantly different between IBD and the control groups (IBD: 52.5%, non-IBD: 52.6%,
Healthy-1: 65.6%, Healthy-2: 53.7%) (Figure 32). When examining the most important
species within the network, defined as the species with the ten highest Eigenvector
centralities, a measure of relative importance or influence of nodes, within a network, all
but two of the ten species were found in the top-10 important species non-IBD or
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healthy networks (Table 2) (Newman 2006). While there was a large amount of overlap,
there were also 56 associations that are unique to the IBD network (Figure 33). The
vast majority of these associations (85.71%) involved species that were elevated in IBD.

Differences in functional capacity
Analysis of the genomic functional capacities of the different cohorts
demonstrated 6 significant differences with greater than two-fold fold change between
the IBD cohort and all other cohorts (Figure 34). IBD samples displayed elevated
relative abundance of protein families involved in sporulation and germination, synthesis
and degradation of polysaccharides, signal transduction, regulatory protein interactions,
and molybdopterin biosynthesis. The IBD samples also displayed reduced relative
abundance of protein families involved in menaquinone and ubiquinone synthesis. Out
of the 34 bacterial species elevated in IBD, 13 were previously found to be associated
with IBD, CRC, IBS, obesity, or rectal bleeding and 8 of the 13 species were found to
have multiple roles (Appendix A). A particular interest within this group of 13 bacteria
were the species that have been studied in vitro or in vivo and found to potentially play a
role in IBD such as Ruminococcus gnavus, Flavonifractor plautii, Clostridium
symbiosum, and Anaerostipes hadrus. Out of the 21 remaining species, 16 were novel
potential markers for IBD, 1 was previously found to be reduced in UC, and 4 were
previously found to be elevated in healthy samples.
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Discussion
This study identified numerous differences in taxonomic profiles, bacterial
association networks, and genomic functional capacity between the IBD gut microbiome
and the control gut microbiomes. Furthermore, our findings were corroborated by
multiple external cohorts, and were generated using techniques and analyses that
account for the compositionality of sequencing data. To our knowledge, this is the first
study to utilize multiple external cohorts from a similar geographic region to corroborate
comparisons between the internal control group and the diseased group in an analysis
of the gut microbiome while also utilizing a compositionally robust methodology.
Additionally, we demonstrated that bacterial species whose relative abundance is
elevated in IBD are also present in the healthy microbiomes and maintain an important
position in the healthy and IBD bacterial association networks implying that these
species play an important role in the gut microbiome. However, these elevated bacteria
are also often implicated in mucin degradation, immune system modulation, antibiotic
resistance, and modulation of inflammation and their over-abundance may dysregulate
these important processes possibly contributing to IBD pathogenesis and IBD-related
symptoms.

We found that the IBD samples had alpha-diversities similar to internal controls
(non-IBD), but significantly lower than external healthy controls. While It has previously
been noted that IBD samples have lower alpha-diversity than healthy controls, we
believe this may be due to the convenience selection of internal controls (Gevers,
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Kugathasan, Denson, Vázquez-Baeza, Van Treuren, et al. 2014; Frank et al. 2011;
Sheehan, Moran, and Shanahan 2015). As reported in Lloyd-Price et. al. 2019, the
internal controls (non-IBD) consisted of “patients [who] were approached for potential
recruitment upon presentation for routine age-related colorectal cancer screening, work
up of other gastrointestinal (GI) symptoms, or suspected IBD, either with positive
imaging (for example, colonic wall thickening or ileal inflammation) or symptoms of
chronic diarrhoea or rectal bleeding”. However, due to ~75% of internal control samples
being derived from subjects below the age of 45 (the earliest recommended age for
colorectal cancer screening without personal or family history of colon cancer), it is
presumed that the majority of these subjects presented with GI distress (Lloyd-Price et
al. 2019) (Figure 35).

When examining the replicates present in the IBDMDB and Healthy-2 cohorts, it
was noted that subjects diagnosed with IBD demonstrated increased temporal
variability, as measured by the intrapersonal dissimilarity, when compared to non-IBD
samples and Healthy-2 samples. This has been previously demonstrated when
comparing CD and UC to non-IBD controls and has been posited to be caused by the
inflammation and decreased intestinal transit time experienced by IBD patients as well
as the medications and lifestyle changes employed to manage IBD (Clooney et al.
2020). It was also noted that the IBD and non-IBD samples displayed greater subject-tosubject variability relative to Healthy-1 and Healthy-2 samples. The relatively elevated
temporal stability and subject-to-subject variability indicates that the gut microbiome of
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our IBD samples displayed increased heterogeneity, relative to healthy controls. This
has also been previously demonstrated in pediatric IBD patients and is believed to be
caused by a depletion of core microbes, possibly due to inflammation and IBD therapies
(Schirmer et al. 2018).

Much like the original publication utilizing the IBDMDB cohort (Lloyd-Price et. al.
2019), differentiating between the taxonomic profiles of IBD from non-IBD samples was
difficult. In our study, using the RFC to classify IBD and non-IBD samples yielded many
misclassifications in which non-IBD samples were consistently classified as IBD. The
non-IBD samples were also misclassified as healthy. This split of RFC misclassifications
for non-IBD samples indicates that the non-IBD group consists of a heterogeneous
group that resembles both the IBD group, such as the subjects presenting with GI
distress, and the healthy groups, such as the subjects presenting for routine screenings.
It was also noted that the RFC utilizing the taxonomic profiles misclassified CD samples
as UC samples and vice versa. This has also been previously demonstrated in other
studies utilizing shotgun sequence data and is indicative of the high similarity
demonstrated between the taxonomic profiles of the CD and UC gut microbiomes
(Moustafa et al. 2018).

The RFC was able to distinguish between the external healthy cohorts and the
IBD samples consistently and accurately, most likely due to these cohorts being
composed of samples with no reported or overt disease. Our modified RFC framework
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also allowed us to distinguish bacterial species that had a higher ranking than the
random feature, based on the RFC feature importance’s. These species were then used
for differential abundance analysis, and network construction. While there was difficulty
distinguishing the non-IBD sample taxonomic profiles from the IBD and healthy sample
taxonomic profiles utilizing the RFC, we were able to distinguish 55 bacterial species
that were significantly differentially abundant between the IBD and non-IBD groups. Of
these 55 species, 42 were differentially abundant with a greater than 2-fold change in
the external cohorts as well.

The bacterial association networks revealed that while some bacteria were found
to be elevated in IBD, they were still present in non-zero degree in non-IBD and healthy
networks. As a matter of fact, the species elevated in IBD displayed higher than
average degree in all networks except for the Healthy-1 network. Furthermore, when
examining the most important nodes (top-10 eigenvector centrality) within the IBD
network, 8 out of the 10 species were also found in the top-10 eigenvector centrality
(EVC) nodes of the healthy networks but all 10 of the top EVC species were found to
have relative abundances that are elevated in IBD samples. The presence and
importance of species that are elevated in IBD appears to be ubiquitous throughout all
networks implying that while these species have an increased relative abundance in
IBD, they still play integral roles within the non-IBD and healthy microbiomes, and that it
is their over-abundance and not mere presence that plays an important role in IBD.
Interestingly, while bacteria with elevated relative abundances in IBD were present and
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appeared to play an important role in the non-IBD and healthy networks, they also
demonstrated many associations unique to the IBD network illustrating that some
bacterial species can associate with different bacteria due to factors other than just the
presence of the bacteria. This implies that other factors, such as host genetics, host
diet, intestinal environment, or medications may lead to the unique associations (PérezGutiérrez et al. 2013; Ohland and Jobin 2015).

It was also noted that the majority of species within each network were not
differentially abundant between IBD and the control groups (IBD: 52.5%, non-IBD:
52.6%, Healthy-1: 65.6%, Healthy-2: 53.8%). This is an interesting finding
demonstrating that the majority of gut microbiome network constituents are similar in
relative abundance between healthy and IBD gut microbiomes. Furthermore, we
observed that these non-differentially abundant bacteria accounted for greater than 60%
of the relative abundances in all groups (IBD: 62.6%, non-IBD: 70.5%, Healthy-1:
74.6%, Healthy-2: 64%). Most bacterial association networks and most of the gut
microbiome were composed of bacteria that are not significantly differentially abundant
between the IBD and control gut microbiomes indicating that the differences in the IBD
gut microbiome are not wide-spread and appear to be limited to a set of bacterial
species with significantly higher relative abundance. Interestingly, it was also observed
that the majority of negative associations found in all networks were associated with
species displaying elevated relative abundance in IBD samples (IBD network: 100%,
non-IBD: 100%, Healthy-1: no negative edges, Healthy-2: 81.6%). This finding indicates
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that the bacterial species elevated in IBD may play an important role in maintaining
stability, possibly by preventing positive feedback loops, but due to their overabundance
in IBD they may contribute to reducing the diversity of the gut microbiome in IBD
samples (Coyte, Schluter, and Foster 2015).

When analyzing the protein family relative abundances in each cohort, we were
not able to identify any statistically significant differences in functional roles between the
IBD and non-IBD group. However, we were able to find 6 significantly different
functional roles between the IBD group and each of the external control cohorts.
Notably, the protein family role most elevated in IBD, relative to external healthy
controls, was associated with functions related to sporulation and germination. While
sporulation in the context of GI disease is most often associated with Clostridium
difficile, many members, especially pathogens, of the Clostridia genus have been found
to utilize sporulation which is in-line with our data demonstrating that the Clostridium
genus is the most commonly elevated genus in IBD (Hookman and Barkin 2009; Shen
et al. 2019). Our analysis also demonstrated that protein families involved in
polysaccharide metabolism were elevated in IBD. This may be due to the increase in
relative abundance of some bacteria that inhabit the intestinal mucosa and degrade
mucin to derive glycans as an energy source, such as Ruminococcus gnavus and
Clostridium symbiosum (Bernalier-Donadille 2010; Hall et al. 2017; Desai et al. 2016). It
was also found that protein families involved in molybdopterin synthesis were
significantly elevated in IBD. Molybdopterin is an important co-factor for nitrate
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reductase, which reduces nitrate to nitrite (Moreno-Vivián et al. 1999). Previous
research has identified nitrite as an important molecule in the regulation of mucosal
blood flow, intestinal motility, and mucus membrane thickness, however it believed that
an over-abundance of nitrite can have deleterious effects on commensal bacteria and
has been shown to be associated with IBD as well as with increased bleeding (Lidder
and Webb 2013; Tiso and Schechter 2015; Park et al. 2013). This may indicate that an
increase in nitrate reduction (leading to increased nitric oxide levels) can contribute to
negative selection against commensal bacteria as well as contribute to increased
propensity of intestinal bleeding in IBD. Nitric oxide, the main metabolite of nitrite, is
also believed to be able to increase intestinal motility and lead to diarrhea (Kukuruzovic
et al. 2003).

We also observed that protein families involved in the synthesis of quinones
(menaquinone and ubiquinone) were reduced in IBD. Quinones are believed to be
important growth factors for gut microbiota, especially for bacteria seen as commensals
(Fenn et al. 2017). Humans are also unable to synthesize menaquinone (Vitamin K) and
thus must ingest it or have it produced by commensal bacteria indicating that a
reduction in vitamin K synthesis by the gut microbiota may lead to a reduction of vitamin
K levels in IBD (Walther et al. 2013). In fact, IBD research has long noted that IBD
patients present with lower vitamin K levels (Schoon et al. 2001; Krasinski et al. 1985).
Due to the important role of vitamin K in blood clotting and calcium binding, this
reduction on vitamin K has been used to explain common co-occurrences and
99

symptoms of IBD such as osteoporosis and bleeding (Schoon et al. 2001; Agnello et al.
2014). Quinone synthesis appears to play an important role in maintaining host health
and its reduction may contribute to the increased intestinal and rectal bleeding common
in IBD.

Finally, we were able to identify specific bacterial species that are elevated in IBD
and play important roles in fomenting inflammation, degrading mucin, and antibiotic
resistance. R. gnavus and C. symbiosum are mucin-degrading bacteria that are found in
healthy gut microbiomes but are shown to be elevated in IBD gut microbiomes (Crost et
al. 2016). These bacteria may play an important role in preventing the over-secretion of
mucus in healthy gut microbiomes, but their over-abundance may cause the mucus
layers in the intestine to become too thin. We also identified Flavonifractor plautii as a
species that was elevated in IBD. F. plautii has been found to degrade flavinoids, an
important anti-inflammatory mediator in humans and mice (Musumeci et al. 2020). The
over-abundance of F. plautii can lead to low levels of flavonoids which has been shown
to lead to increased inflammation, particularly in the gut microbiome (Gupta et al. 2019).
R. gnavus, C. symbiosum, and F. plautii are key examples of bacterial species that are
present, and potentially important, in healthy microbiomes but appear to exhibit
deleterious effects on host health when they become over-abundant.
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While we attempted to mitigate as many confounders under our control as
possible, there are still limitations to be cognizant of within our study. One very
important limitation stems from the relatively low number of subjects present in the
datasets we utilized. We previously demonstrated that as the sample-to-taxa ratio
increases, our network inference framework generates better predictions (Loftus,
Hassouneh, and Yooseph 2021), however, due to the low number of unique individuals
it was necessary to construct the networks using the replicates as individual samples.
While we have demonstrated that the intrapersonal variation is lower than the
interpersonal variation, we do not believe that this has a negative effect on the accuracy
of the networks inferred. Due to the assumption that the samples in a group are all
generated using the same underlying covariance structure, it is reasonable to include
subject sample replicates for network inference. Another potential limitation was a bias
towards samples from younger subjects in the IBDMDB cohort. Approximately half of
(46.6%) IBDMDB samples were derived from subjects below the age of 18 (Figure 35a)
and the youngest subject was 6 years of age. In contrast, no subjects in the Healthy-2
cohort were below the age of 18 (Figure 36). While we did not have access to the
metadata (other than sex) of the Healthy-1 cohort, it was previously published that all
subjects fell between the ages of 18-40 (Methé et al. 2012). The feature ‘age’ also
displayed the greatest feature importance during classification according to our RFC
framework, indicating that there was a non-trivial difference in the ages between the
diagnosis groups. It has been previously observed that the taxonomic profiles of
individuals begin to resemble adult configurations by 3 years of age, indicating that the
bias is unlikely to contribute to major differences in the taxonomic profiles and may just
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be indicative of the younger age of subjects in the IBDMDB study (Yatsunenko et al.
2012). However, the same study did note that while interpersonal variation greatly
decreased after 3 years of age, it was still significantly higher in subjects between the
ages of 3-17, relative to adults (18+ years of age), which may explain some of the
difference in interpersonal variability observed between IBD and non-IBD samples,
relative to the Healthy-1 and Healthy-2 samples. Finally, it was noted that there was a
greater proportion of female subjects in the Healthy-2 cohort relative to the Healthy-1
and IBDMDB cohorts (Figure 37). This does not appear to impact the classification
results however, as the RFC did not find the features ‘sex’ to be more important than
random noise.

By utilizing two external control cohorts, we were able to identify and corroborate
34 bacterial species whose relative abundance is significantly elevated in IBD. These
species appear to play important roles in all bacterial association networks (IBD, nonIBD, and external healthy controls) implying that while an elevation of their relative
abundance is associated with IBD, they are also important to the function of healthy gut
microbiomes. Furthermore, we identified important differences in functional capacities
between IBD and the healthy controls that may contribute to the onset or exacerbation
of IBD-related symptoms such as diarrhea, intestinal bleeding, mucin degradation, and
intestinal inflammation. Finally, we were able to corroborate many of the bacterial
species we identified as elevated in IBD using previously published research and
identified 17 novel bacterial species that may play an important role in IBD. To the best
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of our knowledge, we are the first to corroborate our analysis of the IBD gut microbiome
by using external cohorts from the same geographic region (US) allowing us to
generalize our findings to the population rather than only our study groups.
Furthermore, we were able to illustrate important potential mechanistic links between
the bacterial species elevated in the IBD gut microbiome and IBD-related symptoms.
Finally, we identified differences in the genomic functional capacity of the IBD
microbiome that bridges previous findings in IBD and IBD-related symptoms with the gut
microbiome.
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Figures

Figure 23: Alpha-diversity of sample groups.
Alpha diversity for each sample group by was calculated using Shannon entropy. The alphadiversity for CD, UC, and non-IBD were not significantly different from each other but all three
were significantly lower than the healthy cohorts. *** indicates a p-value < 0.0005 compared to
CD, UC, and non-IBD, using a Mann-Whitney U test.
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Figure 24: Effect of read depth on Shannon diversity.
To illustrate that the alpha-diversity value differences were not due to read depth,
the read depth was plotted against the alpha-diversity (Shannon entropy). Read depth did not
appear to have an effect on alpha-diversity and notable the Healthy-2 cohort had lower read
depth but displayed greater alpha-diversity.
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Figure 25: Intrapersonal and interpersonal variation.
Bray-Curtis dissimilarities between replicate samples from the same subject were used to
quantify intrapersonal variation while the Bray-Curtis dissimilarities between samples from
different subjects were used to quantify interpersonal variation. a. It was observed that replicate
samples from the same subject were significantly more similar to each other than to samples
from other subjects. *** indicates a p-value < 0.0005. b. IBD samples demonstrated elevated
intrapersonal variation relative to non-IBD and Healthy-2 samples and non-IBD samples
demonstrate elevated intrapersonal variation relative to Healthy-2 samples. IBD and non-IBD
samples both demonstrated elevated interpersonal variation relative to the Healthy-1 and
Healthy-2 samples. *** indicates p-value < 0.0005, relative to Healthy-1. +++ indicates p-value
< 0.0005, relative to Healthy-2. ^^^ indicates a p-value < 0.0005, relative to non-IBD.
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Figure 26: Classification accuracy and misclassification before combining CD and UC
into one IBD group.
An RFC was trained on the taxonomic profiling data and metadata (age, sex, unique
subject ID) for all groups without combining the CD and UC groups into one group. a. The RFC
demonstrated poor classification accuracy when attempting to distinguish all groups (CD, UC,
non-IBD, and Healthy), especially when attempting to classify the CD, UC, and non-IBD groups.
b. The largest amount of misclassifications occurred due to the RFC classifying CD samples as
UC and vice versa implying that the taxonomic profiles of both groups were very similar.
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Figure 27: RFC classification accuracy by diagnosis label after grouping CD and UC as IBD.
An RFC was trained on the taxonomic profiling data and metadata (age, sex, unique
subject ID) for all groups after combining the CD and UC groups into one group, known as the
IBD group. a. The RFC demonstrated better classification accuracy (weighted average of 0.87)
compared to previous RFC without combining CD and UC samples under the IBD umbrella
(weighted average of 0.79), however, non-IBD samples were still difficult to classify. b. The nonIBD samples were still consistently misclassified and were split (with a bias towards being
classified as IBD) between being classified as IBD and Healthy samples.
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Figure 28: Differential abundance of bacterial species when comparing IBD to non-IBD and
healthy groups.
Relative abundance values were CLR-transformed and differential abundance was calculated for
IBD compared to non-IBD, IBD compared to Healthy-1, and IBD compared to Healthy-2. The
species that were significantly differentially abundant in IBD relative to every single other group
were considered to be significantly differentially abundant resulting in 42 significantly
differentially abundant bacterial species. Of these 42 species, 34 were found to be significantly
more abundant in IBD relative to every other group and 8 bacterial species were found to be
significantly less abundant in IBD, relative to every other group. The transformed relative
abundances were then averaged and displayed under one label (non-IBD/Healthy) for ease of
visualization. * indicates a q-value < 0.05. ** indicates a q-value < 0.01. *** indicates a qvalue < 0.001.
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Figure 29: Genera counts of bacteria elevated in IBD.
The genera of the bacteria that were elevated in IBD, according to the differential
abundance analysis, were counted. Clostridium and Blautia were the most commonly
elevated genera in IBD samples. Lachnoclostridium, Ruminococcus, Dorea, and Eubacterium
were the only other genera to have more than one member elevated in IBD.
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Figure 30: Gut microbiome bacterial association networks.
The GGM framework was used to generate bacterial association networks from CLRtransformed relative abundances. The bacterial species (nodes) were colored based on the
differential abundance analysis and the node sizes were based degree of each node within the
network. Bacterial species that were elevated in IBD were still present, and in high degree, in the
non-IBD and healthy networks. It was also noted that the most common constituents of the
bacterial association networks were bacteria that were not significantly differentially abundant
in IBD, relative to the healthy and non-IBD groups. Finally, the IBD networks demonstrated
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more negative edges when compared to the non-IBD and healthy groups. a: IBD network, b:
non-IBD network, c: Healthy-1 network, d: Healthy-2 network.
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Figure 31: Average degree of bacterial species that are elevated in IBD within each
network.
The average degree of the bacterial species that were elevated in IBD was calculated for each
group and compared to the average degree of species not elevated in IBD (elevated in Healthy or
not significantly different). On average, the species elevated in IBD displayed a higher number
of connections (degree) within the bacterial association networks of all diagnosis groups and
was significantly higher in 3 out of the 4 networks.
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Figure 32: Network node compositions.
The Majority of nodes for each network are composed of species that are not
differentially abundant between IBD and the other diagnosis groups.
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Figure 33: Unique associations within the IBD bacterial association network.
When comparing the structure of the IBD bacterial association network to all other
networks, 56 associations were found that were unique to IBD networks only. The majority
(85.7%) of these associations involved bacteria elevated in IBD. Even though the bacteria
elevated in IBD are also present in the control networks, and in high degree, they do appear to
demonstrate different associations in the IBD network.
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Figure 34: Differences in IBD gut microbiome functional capacity.
Genomic functional capacity was determined by using the TIGRFAM protein family database.
The counts for each TIGRFAM within a bacterial species were weighted by the relative
abundance of the bacterial species within each group. The CLR-transformed relative abundance
of the TIGRFAM’s within IBD were then compared to the non-IBD, Healthy-1 cohort, and
Healthy-2 cohort individually. The differentially abundant TIGRFAM’s were then summed based
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on their roles, according to the TIGRFAM database. There were no differences between the IBD
and non-IBD gut microbiome functional capacities. There were 6 significantly differentially
abundant protein family roles when comparing IBD to the Healthy-1 cohort that were also found
in the Healthy-2 cohort. These differences are implicated in important processes that may
contribute to IBD-related symptoms such as diarrhea, intestinal bleeding, and increased
intestinal permeability. The relative abundances of the Healthy-1 and Healthy-2 cohort
TIGRFAM roles were averaged for ease of visualization. * indicates a p-value < 0.05. **
indicates a p-value < 0.01. *** indicates a p-value < 0.001.
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Figure 35: Age groups within the IBDMDB cohort and non-IBD samples.
The counts of age ranges for subjects from the IBDMDB cohort were plotted. a.
Almost half (46.6%) of samples in the IBDMDB cohort were from subjects below the age 18. b.
The majority of non-IBD samples were derived from subjects that fell below the age of 45, the
recommended age for colorectal cancer screening. Due to the description of subject recruitment
from the original publication (Lloyd-Price et. al. 2019), it is presumed that the majority of the
control group were comprised of samples that presented for GI distress or suspected IBD.
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Figure 36: Age ranges of Healthy-2 samples.
The age range for subjects of the Healthy-2 cohort were plotted. The vast majority
of subjects are between 18 and 44 and no samples are below 18 years of age.
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Figure 37: Sex counts by cohort.
The counts of samples from a subject of a given sex were plotted for each cohort.
There appears to be a greater proportion of females in the Healthy-2 cohort relative, but the
IBDMDB and Healthy-1 cohorts appear to have similar proportions of each sex.
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Tables
Table 2: Top-10 eigenvector centralities (EVC) per sample group.
Eigenvector centrality (EVC) of each node (bacterial species) in the IBD network was
calculated. The ten nodes with the highest EVC in IBD were also found in the top-ten EVC nodes
of the non-IBD, Healthy-1, or Healthy-2 networks except for Fusicatenibacter saccharivoran
and Blautia hansenii.
Species

EVC

Diagnosis Group

Blautia_sp_N6H115

0.342211

IBD

Hungatella_hathewayi

0.313393

IBD

Blautia_obeum

0.304794

IBD

Clostridium_citroniae

0.289837

IBD

Clostridium_bolteae

0.283886

IBD

Agathobaculum_desmolans

0.274133

IBD

Fusicatenibacter_saccharivorans 0.266944

IBD

Blautia_hydrogenotrophica

0.258565

IBD

Clostridium_symbiosum

0.255309

IBD

Blautia_hansenii

0.202126

IBD

Blautia_sp_N6H115

0.357233

non-IBD

Blautia_obeum

0.297542

non-IBD

Clostridium_symbiosum

0.294405

non-IBD

Hungatella_hathewayi

0.281785

non-IBD

Blautia_hydrogenotrophica

0.265395

non-IBD

Clostridium_bolteae

0.252532

non-IBD

Ruminococcus_gnavus

0.25097

non-IBD

Clostridium_citroniae

0.247998

non-IBD

Anaerostipes_hadrus

0.20174

non-IBD

Agathobaculum_desmolans

0.201307

non-IBD

Bacteroides_fluxus

0.368378

Healthy-1

Bacteroides_caecimuris

0.33475

Healthy-1

Bacteroides_plebeius

0.322128

Healthy-1

Bacteroides_coprocola

0.255504

Healthy-1

Bacteroides_coprophilus

0.251902

Healthy-1

Bacteroides_ovatus

0.250976

Healthy-1

Butyricimonas_sp_H184

0.244785

Healthy-1

Bacteroides_fragilis

0.23319

Healthy-1

Bacteroides_thetaiotaomicron

0.218279

Healthy-1
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Species

EVC

Diagnosis Group

Bacteroides_vulgatus

0.209061

Healthy-1

Fournierella_massiliensis

0.382647

Healthy-2

Provencibacterium_massiliense

0.331834

Healthy-2

Subdoligranulum_variabile

0.327014

Healthy-2

Ruthenibacterium_lactatiformans 0.281926

Healthy-2

Faecalicatena_contorta

0.247965

Healthy-2

Clostridium_bolteae

0.245986

Healthy-2

Merdibacter_massiliensis

0.234116

Healthy-2

Clostridium_asparagiforme

0.211324

Healthy-2

Butyricicoccus_pullicaecorum

0.205136

Healthy-2

Blautia_hydrogenotrophica

0.166324

Healthy-2
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CHAPTER 4: CONCLUSION
To understand the effects caused by changes in the gut microbiome, analysis
cannot be restricted to an examination of the presence, absence, or relative
abundances of bacteria within the community. It is also important to examine the
bacterial associations that compose the microbiome as well as the functional
implications of the changes in the gut microbiome. To this end, we used WGS
sequencing data to enable us to accurately identify changes in species-level taxonomic
profiles and functional capacity of the microbiomes. We also used log-ratio
transformations to account for the compositional nature of the sequencing data and
developed a Graphical Gaussian Model to accurately infer bacterial associations.
Finally, we included multiple independent cohorts to ensure that our findings could be
replicated in independent cohorts thereby corroborating our findings.
Firstly, we studied four independent healthy cohorts from different geographic
regions to examine the variation in the healthy gut microbiome and identify patterns
within the human gut microbiome that may be associated with health. While we found
significant variation in the differential abundances of the bacteria in the gut microbiome,
approximately 95% of bacterial species were present in all cohorts, indicating a
significant overlap in the presence of bacterial species across healthy subjects.
Bacterial association networks of the healthy gut microbiomes also exhibited many
similarities in their properties and demonstrated conserved structures. Specifically, 20
bacterial species were found to have the same 14 associations amongst each other
across all healthy cohorts. All bacterial association networks also exhibited a preference
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for species with similar taxonomy or function to associate positively with one another.
Finally, analysis of functional capacity of all healthy cohorts demonstrated little variation,
indicating that healthy populations have similar functional capabilities regardless of the
differences in bacterial differential abundances. We demonstrate that gut microbiomes
across healthy human populations from different geographical regions have similar
species present, similar association network organization and properties, and similar
functional capacities. These findings demonstrate that while possible differences within
cohorts exist due to diet, genetics, and other geographically distinct influences, there is
still a large amount of similarity within healthy gut microbiomes.
Next, we used WGS sequencing of IBD patients to identify important differences
between American IBD gut microbiomes and American healthy subjects. To corroborate
our findings and increase their generalizability, we utilized two independent healthy
cohorts as well as the internal control group. We identified 34 bacterial species that
were significantly elevated in IBD. While these species were elevated in IBD, they still
appeared to play important roles, as measured by the number of associations they were
involved in, in the bacterial association networks of the healthy gut microbiome.
Additionally, analysis of functional capacity of the IBD gut microbiome revealed lower
capacity for menaquinone synthesis, an essential vitamin (vitamin K) not produced by
humans, which is involved the regulation of osteoporosis and rectal bleeding. The
functional capacity analysis also revealed an increased capacity for nitrate reduction
which can contribute to intestinal bleeding, as well as increased intestinal motility
leading to diarrhea. It was also revealed that IBD gut microbiomes displayed elevated
capacity for polysaccharide metabolism, possibly due to the increased relative
135

abundance of known mucin-degrading bacteria such as Rumincoccus gnavus,
Rumincoccus. torques, and Clostridium symbiosum. These findings illustrate a link
between the gut microbiome and IBD-related symptoms as well as provide potential
targets for symptom management in IBD patients.
By using WGS sequencing in conjunction with compositionally appropriate
analysis and network inference, we identified important species-level patterns in the
relative abundances, community interactions, and functional capacity of the human gut
microbiome in healthy subjects and IBD patients. Furthermore, the identified patterns
were compared in the context of health and disease and some patterns were found to
be associated with IBD-related symptoms such as rectal bleeding, diarrhea,
inflammation, and mucin degradation. Finally, we corroborated our findings by using
multiple healthy cohorts to ensure that our results are robust and are not limited to
cohort-specific signals. Our findings illustrated that the gut microbiome is linked to IBDrelated symptoms and identified specific pathways and bacterial species as potential
targets in the management of IBD symptoms.
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APPENDIX A: DIFFERENTIALLY ABUNDANDANT BACTERIAL
SPECIES
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Species

Differential
Abundance

Search
Results

Flavonifractor
plautii

Elevated in
IBD

Faecalicatena
contorta
Blautia
hydrogenotrophica
Clostridium
citroniae
Lachnoclostridium
sp_YL32
Oscillibacter
sp_PEA192

Elevated in
IBD
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD

Clostridium
symbiosum

Elevated in
IBD

Blautia obeum

Clostridium bolteae

Ruminococcus
gnavus

Blautia hansenii
Blautia sp_N6H115

Function

Keywords

Citations

Associated
with IBD

Degrades
beneficial
flavinoids

Inflammatory

(Gupta et al. 2019;
Musumeci et al. 2020)

Novel

Novel

Novel

Novel

Associated
with IBD
Associated
with IBD

Multi-drug
resistance

Antibiotic
resistance

Novel

Novel

Novel

(Rodriguez et al. 2020)

Associated
with IBD

Novel
(Liang et al. 2019)

Novel

Novel

Novel

Novel

Transfers
vanB genes
to
commensals

Antibiotic
resistance,
Mucin-related

(Xie et al. 2017; Launay
et al. 2006)

Elevated in
IBD

Associated
with CRC
and rectal
bleeding
Elevated in
Healthy

Elevated in
IBD

Associated
with IBD

Foments
TNF-a from
dendritic
cells

Mucin-related,
Inflammatory

(Hall et al. 2017;
Beaud, Tailliez, and
Aba-Mondoloni 2005;
Henke et al. 2019;
Chua et al. 2018; Imam
et al. 2018; Hansen,
Skov, and Justesen
2013; Crost et al. 2016)

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Elevated in
IBD
Elevated in
IBD

(Theriot and Petri 2020)

Merdimonas faecis

Elevated in
IBD

Dorea
formicigenerans

Elevated in
IBD

Associated
with
obesity
Associated
with IBD

Clostridium
asparagiforme

Elevated in
IBD

Elevated in
Healthy

Intestinibacter
bartlettii

Elevated in
IBD

Novel

Novel

Ruminococcus
torques

Elevated in
IBD

Associated
with CD

Hungatella
hathewayi
Butyricicoccus
pullicaecorum
Agathobaculum
desmolans

Elevated in
IBD
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD

Associated
with CD
Elevated in
Healthy

Associated
with upper
GI
involvement

Dorea longicatena

Novel

(Schoch et al. 2012)
(Nomura et al. 2005)
(Lett, Costello, and
Roberts-Thomson
2020)
Novel

Novel
(Kwak et al. 2020)
(Rodriguez et al. 2020)
(Eeckhaut et al. 2013)

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel
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Fusicatenibacter
saccharivorans
Erysipelotrichacea
e bacterium
Holdemania
massiliensis
Lachnoclostridium
phocaeense
Negativibacillus
massiliensis

Differential
Abundance
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD
Elevated in
IBD

Clostridium
scindens

Elevated in
IBD

Novel

Anaerostipes
hadrus

Elevated in
IBD

Associated
with IBD

Subdoligranulum
variabile

Elevated in
IBD

Associated
with IBS

Faecalibacterium
prausnitzii

Elevated in
IBD

Associated
with
Healthy

Antiinflammatory

Mordavella
sp_MarseilleP3756

Elevated in
IBD

Novel

Novel

Species
Fournierella
massiliensis
Eubacterium hallii

Search
Results

Function

Keywords

Citations

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Novel

Steroid signaling

(Morris, Winter, and
Cato 1985)

Inflammatory

(Zhang et al. 2016)

Inflammatory

(Sundin et al. 2015)

Modulates
steroid
signaling
Exacerbates
inflammation
in mice with
colitis
Cytokine
release in
PI-IBS
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(Zhao et al. 2020; Zhou
et al. 2018; Breyner et
al. 2017; Burkqvist et al.
2019)
Novel

Novel
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